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ABSTRACT 
 
Biomass synthesis is a competing factor in biological systems geared towards generation 
of commodity and specialty chemicals, ultimately limiting maximum titer and yield; in 
this thesis, a widely generalizable, modular approach focused on decoupling biomass 
synthesis from the production of the phenylalanine in a genetically modified strain of E. 
coli BW25113 was explored with the use of synthetic trans-encoded small RNA (sRNA) 
to achieve greater efficiency. The naturally occurring sRNA MicC was used as a scaffold, 
and combined on a plasmid with a promoter for anhydrous tetracycline (aTc) and a 
T1/TE terminator. The coding sequence corresponding to the target binding site for 
fourteen potentially growth-essential gene targets as well as non-essential lacZ was 
placed in the seed region of the of the sRNA scaffold and transformed into BW25113, 
effectively generating a unique strain for each gene target. The BW25113 strain 
corresponding to each gene target was screened in M9 minimal media; decreased optical 
density and elongated cell morphology changes were observed and quantified in all 
induced sRNA cases where growth-essential genes were targeted. Six of the strains 
targeting different aspects of cell division that effectively suppressed growth and resulted 
in increased cell size were then screened for viability and metabolic activity in a scaled-
up shaker flask experiment; all six strains were shown to be viable during stationary 
phase, and a metabolite analysis showed increased specific glucose consumption rates in 
induced strains, with unaffected specific glucose consumption rates in uninduced strains. 
The growth suppression, morphology and metabolic activity of the induced strains in 
BW25113 was compared to the bacteriostatic additives chloramphenicol, tetracycline, 
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and streptomycin. At this same scale, the sRNA plasmid targeting the gene murA was 
transformed into BW25113 pINT-GA, a phenylalanine overproducer with the feedback 
resistant genes aroG and pheA overexpressed. Two induction times were explored during 
exponential phase, and while the optimal induction time was found to increase titer and 
yield amongst the BW25113 pINT-GA murA sRNA variant, overall this did not have as 
great a titer or yield as the BW25113 pINT-GA strain without the sRNA plasmid; this 
may be a result of the cell filamentation.  
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1. INTRODUCTION, MOTIVATION, AND BACKGROUND  
1.1 The Current State of Chemical Processing 
Petroleum, natural gas and coal have traditionally played large roles in the chemical 
process industries, and they all have one thing in common – they are not renewable 
resources which will eventually be depleted. Adding to this, these three sectors combined 
generated 4.77 Gt of CO2 in the year 2004, with the entirety of the manufacturing 
industry generating 9.73 Gt of CO2 in that year.1 To put this a bit more into perspective, 
the entire manufacturing industry includes the sectors which are responsible for the 
generation of both electricity (3.59 Gt) and heat (0.29 Gt).1 While it is hard to 
conceptualize a cost competitive alternative to any major manufacturing process which is 
entirely renewable and generates less CO2 amongst other pollutants, certainly alternative 
approaches exist which may address the inevitable issues facing the manufacturing 
industry, and the chemical process industries in particular. Honing in in the chemical 
process industries, a subset of the manufacturing industries estimated to have generated 
3.3 Gt of CO2 in 2005, is perhaps one of the areas with most potential for alternative 
processes.2 Not only would an alternative route of synthesis have the potential to greatly 
diminish associated emissions, but it could also incorporate renewable feedstock, 
generate high yield and titer, making it potentially more lucrative in the long run; 
amongst the most popular of the alternative approaches taken to generate commodity and 
precious chemicals has been bacterial synthesis.3  
The potential of using bacteria as a biocatalyst is edified by considering the current 
means of synthesis for many commodity and specialty chemicals; not only does a route of 
biological synthesis offer a more sustainable means of generating a desired product that 
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need not be reliant on nonrenewable resources, these biological processes have also been 
shown to be effective on an industrial scale.3-4 As an example to elucidate the potential of 
industrial scale biological processes which may use a renewable feedstock, acetone may 
be taken into consideration; acetone has been one of the biggest commodity chemicals 
throughout the past decade, amassing an industry valued at $28 million per year.4 
Although now primarily synthesized through the cumene process, which uses petroleum 
distillates as a precursor, acetone was at one time primarily synthesized through the 
Weizmann process, which relied on the anaerobic fermentation of C. acetobutylicum; at 
the height of WWI, the Weizmann process even warranted the generation of 2,000 lb of 
acetone per week in one single plant, located in King’s Lynn, Great Britain.4 The 
Weizmann process was also sustainable, with another plant located in South Africa that 
produced acetone from a molasses feedstock until 1982.4 Unfortunately, as is the case 
with far too many biologically viable industrial scales routes of synthesis, the cumene 
process replaced the Weizmann process as the latter was only able to generate roughly 
0.1 kg of acetone per kg of feedstock, while the former was able to generate 0.45 kg of 
acetone per kg of cumene, as well as generating a significant amount of phenol as a 
lucrative by-product.4-5 Aside from just higher yields, the cumene process also has the 
inherent benefits of phenol co-generation while avoiding some of the trickiness of 
working with biological systems, like contamination; nonetheless, the Weizmann process 
shows that such large scale biological processes based on fermentation mechanisms have 
potential.5 Even with the Weizmann process, not all hope is lost; much recent research 
and development has gone into generating thorough economic profiles for anaerobic 
fermentation of C. acetobutylicum which consider the harvest of other fermentation 
  3 
 
 
products such as ethanol and butanol, modifying the feedstock composition to incorporate 
cheap and abundant resources like wheat straw, and genetically modifying the bacteria 
through different approaches to produce greater yields and final concentrations of 
desireables.4,6 Appropriately engineering the factors which influence the productivity and 
yield of these biological processes, from operating conditions to gene expression, may 
once more make them competitive with the now-traditional routes of synthesis; a case 
study revisiting this anaerobic fermentation process with C. beijerinckii found production 
of acetone at a selling price of $1.30 per kg to be viable through rational engineering 
techniques, while market value throughout the past decade has hovered at the same 
levels.3,6,7,8 
1.2 The Potential for Bacteria in the Chemical Process Industries  
It takes much insight attained through thorough research and development to identify 
good candidates for industrial scale production with a biocatalyst however; as with any 
chemical reaction, thermodynamic and kinetic constraints must be taken into 
consideration.9 In a most fundamental sense, thermodynamics is important in determining 
if a reaction will favor the products or reactants, while kinetics determines how fast the 
reaction will achieve a steady state; together, these give a good measure for the energy 
associated with the system.10-11 One of the most convenient ways to measure the 
thermodynamics of a given reaction is through the Gibbs free energy, an intangible 
quantity which may be calculated through measureable physical quantities.11 Reactions 
with negative Gibbs free energy values are spontaneous, generating energy, while 
reactions with a positive Gibbs free energy value are non-spontaneous, requiring the 
input of energy.11 Therefore if a reaction has a negative Gibbs free energy, it will be 
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product favored; furthermore, in a biological system, if a given reaction has a positive 
Gibbs free energy then energy must be supplied by the cell. The more negative the Gibbs 
free energy is, the more spontaneous the reaction, and the more product favored it 
becomes; equilibrium constants are common indirect measures of the Gibbs free energy 
that give light to the relative ratio of the mole fraction of products relative to reactants.11 
The relationship between the total Gibbs free energy of a reaction G, the equilibrium 
constant K, and the mole fraction of a given species in the liquid phase xi is expressed 
below for the sake of clarity,11 
ln(𝐾𝐾) = − ∆G(R ∗ T) 
𝐾𝐾 = 𝛱𝛱(𝑥𝑥𝑖𝑖 ∗ 𝛾𝛾𝑖𝑖)𝜈𝜈𝑖𝑖 
In the relationship above, the gas constant R, temperature T, activity coefficient, γi, and 
stoichiometric coefficient, νi are required; furthermore, this simplified version is only 
valid for low to moderate pressure.11 The Gibbs free energy is useful in genetic 
engineering as it may enable enhanced insight into competing reaction pathways. 
Assuming the reaction kinetics are equivalent, this relationship dictates the more 
spontaneous pathway will most likely generate more product.11 This example also 
reiterates a critical point - kinetics must be taken into account. If the kinetics are 
favorable enough, they may act as a driving force to help mitigate some thermodynamic 
constraints; this is particularly useful genetic engineering because in its essence, all 
genetic engineering approaches modify the thermodynamics and kinetics involved with 
different cellular processes. In a similar fashion to the way the previous example 
highlighted the importance of Gibbs free energy in a set of competing reactions, the 
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importance of kinetics may be brought to light by considering the two reactions again 
seen in Figure 1,  
 
Figure 1: The Gibbs Free Energy versus Reaction Coordinate for Two Arbitrary 
Reactions (Solid, Dashed). Reaction A is More Thermodynamically Favorable, Indicated 
by the Greater Overall Change in Gibbs Free Energy, but Less Kinetically Favorable, 
Indicated by the Larger Activation Energy. 
As seen above, there exist two reactions A and B, which may be represented by a solid 
line and a dashed line respectively; the two reactions both only have one intermediate 
formed during the overall reaction process, indicated by only one local maxima of Gibbs 
free energy, and this may be referred to as the activation energy for each reaction.11 By 
inspection, reaction A has a larger activation energy, as it has the obviously larger 
increase in Gibbs free energy near the start. Under a resource limited scenario, even 
though reaction A is more thermodynamically favorable, kinetic constrains reflected by a 
higher activation energy may result in reaction B using a greater majority of the 
resources.11,12 These are important considerations to take into account when considering 
the sophisticated reaction pathways that make up biological processes; in the context of 
biological systems, thermodynamics and kinetics may be finely tuned to express a desired 
phenotype.12  
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1.3 E. coli as a Candidate for Biosynthesis Applications  
Although C. acetobutylicum was used to make a point in regards to the industrial 
feasibility of biological processes, amongst the most studied bacterial organisms is E. 
coli; with a rich history of pioneering breakthroughs in synthetic biology, different strains 
of E. coli have been shown capable of synthesizing diverse classes of molecules ranging 
from free fatty acids to phenolic compounds which may be used as fuels, specialty 
chemicals, and precursors.13,14 It is worth noting that quite frequently these natural 
pathways are limited by the genes and enzymes native to the host strain, so synthetic 
components to enhance, repress and block native gene expression, or even enable foreign 
gene expression may be incorporated through various genetic engineering 
techniques.3,12,15 Genetic engineering coupled with advances in synthetic biology enable 
these enhancements such as the construction of synthetic pathways, but pathways do not 
have to be completely synthetic – they may branch from an existing pathway as will be 
discussed in Figure 2.3,12,16,17 E. coli is a popular candidate in genetic engineering because 
there is so much known about it – it has a relatively fast growth rate compared to other 
bacteria, it may be grown in a broad range of conditions and it is also found in humans; 
E. coli was also the organism where cloning was observed for the first time, and one of 
the first organisms to have its genome completely sequenced.18,19  With this in mind, 
using bacteria like E. coli seems like a viable solution to the growing problem associated 
with non-renewable resources; just insert a pathway for a desired product, if necessary, 
and fine-tune the thermodynamics and kinetics of the process. Unfortunately, genetic 
engineering is not that easy; there are an unquantifiable number of different strains of E. 
coli alone, each with their own profits and conflicts, with endless numbers of approaches 
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and techniques taken to achieve the perfect balance of kinetics and thermodynamics. As 
an example to show the complexity of metabolic engineering in a real biological system, 
consider the synthesis of phenol from glucose via an extension of the shikimate pathway 
in E. coli as seen below in Figure 2,17,20 
 
Figure 2: Three Synthetic Pathways for the Generation of Phenol from Chorismate 
During Fermentation in E. coli.17 
In the figure above, there are three synthetically engineered pathways which branch from 
the shikimate pathway that may potentially be inserted into E. coli; from a 
thermodynamic standpoint, the first pathway might be the least favorable as it has the 
highest Gibbs free energy, but considering the kinetics of the enzymes involved in each 
step of the reaction cascade, this might not be the case.17 Some enzymes may have higher 
activities, resulting in a scenario analogous to before, where kinetics have a greater 
influence than the thermodynamics. In any case, it is clear that genetic engineering 
coupled with advances in biosynthesis have unleashed a whole new world of target 
chemicals which may be synthesized using biocatalysts.  
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1.4 Metabolic Engineering: Applied Biosynthesis  
In essence, while it is certain that the sustainable technology of industrial scale biological 
synthesis exists, it is also clear that an optimization of the associated operating costs is 
necessary if this is to be cost competitive; even in the revisited case of the C. beijerinckii, 
unless the process is able to bring acetone to market significantly below $1.30 per kg, 
there is no incentive for the main producers of this chemical to invest in such a change.6  
Nonetheless, within the realm of bioengineering, approaches oriented at bringing the 
price point down by addressing factors associated with the viability of the cell have 
garnered much attention; the rational engineering of cellular systems with the ultimate 
goal of expressing a desired metabolic phenotype is one prominent means of fine tuning 
the balance between thermodynamics and kinetics.9,12,21 In essence, this is the underlying 
principle of metabolic engineering and is focused on the optimization of both intracellular 
and extracellular factors; it is worth noting metabolic engineering is not limited only to 
genetic and other intracellular approaches but rather any factor which may induce a given 
desired metabolic phenotype, such as environmental factors.9,12,21,22 Often times the 
ultimate goal is to increase the productivity and final concentration of a target chemical 
when considering the use of biocatalysts in conjunction with metabolic engineering, 
though metabolic engineering also has other uses; for example, metabolic engineering 
may be used to build switchboards and circuits to act as sensors for particular 
environmental markers.23,24  
1.5 Extracellular Factors in Metabolic Engineering  
As mentioned, there are a lot of factors at play when considering metabolic engineering 
and these factors may either be extracellular or intracellular. One of the most prominent 
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extracellular factors in metabolic engineering is the presence of oxygen; in the case of C. 
acetobutylicum, anaerobic fermentation was used to achieve the industrial scale synthesis 
of acetone, but quite often biosynthesis with E. coli operates under aerobic conditions.4,16 
Though it is worth noting E. coli can still undergo respiration and fermentation under 
anaerobic conditions, growth conditions are much different relative to aerobic conditions; 
in general, less ATP is generated per mole of feedstock in anaerobic conditions, resulting 
in severely reduced cell densities, and reduced productivities.25 As the lack of oxygen 
makes it difficult for cell growth, even though productivities are lower relative to aerobic 
systems, yields may approach values close to their theoretical limits because less of the 
ATP is used on biomass synthesis – this leaves more ATP for the production of the target 
chemical.12, 26 While anaerobic growth conditions have their own profits, some cell 
products require a relatively large amount of energy to produce, relating back to the 
analogies discussed in Figure 1 and Figure 2.12 For such target chemicals, production is 
often tied with growth meaning a large amount of biomass must be generated for the co-
generation of a significant quantity of a desirable.12 Other products are also synthesized 
in close relation to cell growth, calling for aerobic conditions in order to be viable.27 To 
mitigate the conflicts of aerobic conditions which may be required for the biosynthesis of 
particular chemicals, diverse approaches in metabolic engineering have been explored to 
decouple growth from production.24,28,29,30 A few metabolic engineering approaches 
aimed at decoupling growth from production will be briefly discussed before presenting 
the central idea of the thesis, which will examine an intracellular approach using 
synthetic small RNA to silence growth essential genes; this approach may be applied to a 
diverse class of target chemicals, enabling the continuation of biosynthesis without 
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biomass accumulation.24 This is advantageous in both the case of the chemicals which 
need large amounts of energy for production and those tied with growth as this allows 
control of biomass formation, and therefore the optimization of titer and yield.  
Nutrient limitation through the use of minimal media feedstock is a popular extracellular 
approach aimed at preventing excess biomass accumulation; in particular, controlling the 
levels of carbon, nitrogen and phosphorous supplied to the cell system may warrant the 
fine tuning of growth and productivity.31,32 Cells need nitrogen and phosphorous for 
reproduction, so tuning the concentrations of these may warrant reallocation of the 
energy in the cell towards production of a desirable.33 A popular way of achieving this is 
through the use of specialized nutrient broths which serve as media to grow the cell 
system in; nutrient limitation in the form of minimal media broth is also applicable for 
gauging efficacy in industrial scale processes as reducing the constituents of the media 
may result in significant savings, though a challenge presented by special growth medias 
used for nutrient limitation are non-traditional culturing protocols introducing more 
potential for mistakes.34 For example, on top of more sophisticated formulas, minimal 
media may require specialized preparation if it is comprised of light or temperature 
sensitive components, or specialized growth if it is not pH buffered.  
Another extracellular metabolic engineering approach geared at stopping biomass 
synthesis is the use of bacteriostatic additives which may disrupt a number of different 
cell mechanisms that warrant the cell to carry out regular metabolic functions but inhibit 
growth; suitable targets for bacteriostatic additives may be genes associated with DNA 
synthesis, protein synthesis, cell wall synthesis, and the cell division process.22, 33,35 
  11 
 
 
Bacteriostatic additives may inhibit growth by acting on a particular gene to result in the 
buildup of a rate-limiting intermediate; the known gene targets of bacteriostatic additives 
also offer a convenient phenotypic comparison to gene silencing based approaches.35 
Unfortunately, scalability issues associated with the use of bacteriostatic additives such as 
strains developing a resistance and cost prohibition make other techniques more attractive 
options. Aside from nutrient limitation and bacteriostatic additives, there are other 
extracellular factors which may influence the metabolism of the cell and may also be 
optimized for biosynthesis, but do not show much potential in regards to decoupling 
growth and from production – factors such as temperature, pH, and aeration may be 
optimized, but are relatively standard depending on the viability of the bacteria.33,22  
1.6 Intracellular Factors in Metabolic Engineering  
Extracellular factors and optimization techniques play a critical role in metabolic 
optimization of bioprocesses and have shown potential to contribute in the separation of 
biomass synthesis and target chemical production, and their successes are only 
compounded when considering approaches taken in metabolic engineering on an 
intracellular, genetic level. Though as is the case with many extracellular factors, many 
genetic oriented metabolic engineering approaches have not been aimed at the decoupling 
of biomass production from synthesis of a target product because the methods of gene 
manipulation are not dynamic in nature, so reducing the activity of genes essential for 
growth would result in poor overall cell performance. Nonetheless, approaches such as 
over-expressing genes responsible for the production of rate-limiting intermediates or 
knocking out genes associated with competing pathways have seen great success in 
increasing overall efficiency of bioprocesses; just as with the extracellular factors 
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discussed above, these approaches offer the potential to be compounded with a dynamic 
genetic approach that turns off biomass synthesis.36,37 As an example of how intracellular 
approaches are useful in metabolic engineering, consider the production of phenylalanine 
which is an essential amino acid. Though not dynamic in nature and does not decouple 
growth from production, without traditional intracellular approaches, significant 
concentrations of phenylalanine in E. coli may not be achieved; consider the pathway 
below which illustrates the production of phenylalanine from glucose, both in green, in E. 
coli,  
 
Figure 3: Pathway Showing Production of Phenylalanine from Glucose 
Considering E. coli does not natively make high levels of phenylalanine, a strain was 
engineered by overexpressing the feedback resistant genes aroG and pheA, seen in red, 
which lead to significant increases in phenylalanine production. Overexpressing these 
genes reduced the flux of the intermediates to alternate pathways; for example, when 
overexpressing pheA more chorismate is used to generate prephenate than before. Just 
overexpressing these two genes can lead to phenylalanine concentrations of roughly 1.5 
grams per liter – so while it is an effective approach, it is worth noting that further 
optimization would be difficult without manipulating other parameters. Finding a 
“global” growth-switch to decouple biomass synthesis from production could enhance 
already existing techniques which focus on “local” pathways like over-expressing genes.  
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One dynamic genetic approach aimed at turning off biosynthesis is governing RNA 
polymerase using an inducible promoter; it was shown that using this technique cell 
growth could be arrested while the cell would remain a metabolically active platform.38 
While this approach even showed success at increasing glycerol production, the lack of 
modularity with respect to gene targets makes this approach tricky as the promoter of 
each desired gene must be replaced on the chromosome if different gene targets are to be 
explored to better fine tune the cell system.38 Another dynamically inducible method that 
can offer selection of genetic targets may not only warrant the exploration of growth 
essential genes on cell viability, but it would also introduce a novel metabolic 
engineering technique applicable to many scenarios even beyond metabolic engineering. 
One way of accomplishing this may be through the use of trans-encoded artificial small 
RNA (afsRNA), an mRNA regulator which acts through limited base pairing and may 
either inhibit translation of a particular gene, or degrade mRNA.39,40  
1.7 Small RNA in Bacteria  
With the discovery of riboswitches, sRNA, and CRISPR RNA, the role of RNA as 
regulators in cell systems has long been acknowledged; considering sRNA in particular, 
the emersion of trans-encoded sRNA in the past decade has unleashed much potential in 
synthetic biology.40,24 Prior to the emersion of trans-encoded sRNA, only cis-encoded 
sRNA was understood; cis-encoded sRNA have extensive homology with a target 
mRNA, around 75 nucleotides, and are located on the opposite DNA strand of the target 
RNA, while trans-encoded sRNA may be around 20 nucleotides and are located separate 
from the target mRNA.39,40 The general structure of trans-encoded sRNA may be seen 
below in Figure 3,39 
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Figure 4: A General Schematic of Trans-encoded sRNA Showing the Seed Region, One 
Potential Hfq Binding site, and the Transcription Terminator.39 
Trans-encoded sRNA is primarily comprised of the three regions seen above – the 
transcription terminator region, an Hfq binding site, and a seed region.39 Perhaps the most 
interesting of the three regions is the seed region; the seed region is the region which 
targets the translation initiation region of a desired mRNA through a homologous 
sequence of nucleotides.41,39 Studies on the seed region have shown that a seed region of 
around 22 nucleotides long with a binding energy of around -35 𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘
𝑚𝑚𝑚𝑚𝑘𝑘
 generates the most 
stable sRNA-mRNA duplex.24,40 Just as interesting is the Hfq protein which binds to the 
Hfq site; in trans-encoded sRNA, it has been shown that Hfq greatly stabilizes sRNA-
mRNA duplex, while in cis-encoded sRNA the presence of Hfq was shown to decrease 
gene silencing effects.30,39,42 Seen below in Figure 4 is a diagram similar to that which 
was presented in Figure 1, bringing to light the importance of kinetics in an environment 
where the total energy change is equivalent, 
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Figure 5: A Diagram of the Reaction Energy versus Reaction Coordinate for the Binding 
of Trans-encoded sRNA and mRNA, Mediated through Hfq.42 
It may be seen in the figure above that the presence of Hfq as a chaperone to trans-
encoded sRNA promotes formation of a sRNA-mRNA duplex. Lastly, the terminator 
region of the sRNA should not be overlooked either; the terminator is indirectly 
responsible for stabilizing the sRNA-mRNA duplex just as much as the Hfq protein, as 
the terminator region has been shown to control stability of the Hfq protein binding to the 
secondary structure of the sRNA.43 In particular, the terminator on sRNA is a rho-
independent transcription terminator which inherently contains a poly(U) tail; it is this 
poly-U tail which has been shown essential for Hfq binding in trans-encoded sRNA, and 
may even be seen in the schematic sRNA in Figure 3.39, 43,42  
In summary, sRNA is a highly modular tool which may be exploited to target growth 
essential genes in order to decouple biomass accumulation and target chemical 
production; placing an appropriately designed afsRNA under a promoter to target a 
desired mRNA may be a robust way to target growth essential genes and increase 
productivity and yield for desirable chemicals. Furthermore, the ability to target a variety 
of different gene targets also makes afsRNA an attractive approach to explore in regards 
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to growth arrest; more than one sRNA may be placed on a plasmid, once more 
compounding the capabilities at hand. 
1.8 Research Aims  
In this thesis, synthetic trans-encoding sRNA using a scaffold based off of the naturally 
occurring MicC sRNA found in E. coli coupled with an additional terminator, the T1/TE 
terminator, and a promoter for anhydrous tetracycline are put on a plasmid with 
streptomycin resistance to first screen fourteen unique gene targets which may be 
potentially essential for growth based on mechanisms responsible for DNA synthesis, 
protein synthesis, cell wall synthesis, and the cell division process in the E. coli K-12 
strain BW25113; to further characterize the growth suppression capabilities of the sRNA 
approach, a known non-growth-essential gene, lacZ is also taken into consideration.24 
Identification of the most qualified sRNA-mediated gene targets, based on an analysis of 
optical density, morphology, cell viability and metabolic activity, was ultimately used as 
criteria when selecting the best gene targets to be further screened in a strain which 
produces phenylalanine. The effect of decoupling growth and production through various 
cellular mechanisms is assessed using the sRNA to determine the best time to stop 
growth during the exponential growth phase for an optimal productivity and titer. The 
efficacy of the sRNA as a means to suppress growth while leaving the rest of the 
metabolism unscathed is compared to common bacteriostatic additives which are known 
to target particular genes. The fourteen candidate genes and lacZ may be seen listed 
below in Table 1 along with their cellular function; it is also worth noting that fabB and 
fabH were simultaneously targeted as well considering the fatty acid biosynthesis 
pathway cannot be blocked by targeting fabH alone, for reasons discussed in the results, 
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Table 1: A List of the Gene Targets Investigated with sRNA 
sRNA Mediated Gene Target Cellular Function 
dnaE DNA Polymerase 
fabB Cell Wall Biosynthesis 
fabB + fabH  
fabD  
fabG  
fabH  
fabI  
folA DNA Synthesis 
folD  
folP  
lacZ Metabolize Lactose/x-gal   
murA Cell Wall Biosynthesis 
rplD Protein Synthesis 
rplP  
rpsD  
rpsE   
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2. MATERIALS AND METHODS 
2.1 Strains and Media  
While wild-type BW25113 was the primary background strain used in the duration of the 
study, many variants of this strain were generated such as the pSRNA variants and the 
pINT-GA variants; furthermore, other strains were used for the purposes of plasmid 
construction. All strains used in this study are listed below in Table 2 (Next Page) E. coli 
DH5-alpha was purchased from New England Biolabs (NEB) and was used for all 
cloning work and plasmid maintenance. E. coli BW25113 was obtained from the Coli 
Genetic Stock Center (CGSC) and served as the host organism for all experiments in this 
study. E. coli NST74 was obtained from the American Type Culture Collection (ATCC) 
and served as the source of the feedback resistant gene pheA101. Z. mobilis ZM4 was 
also sourced from the American Type Culture Collection (ATCC), and served as the 
source of the promoter for the pyruvate decarboxylase (PDC) gene. E. coli MG1655 
served as the source of the lacZ gene and was generated from D. R. Nielsen on behalf of 
A. Kato. E. coli strains were routinely cultured at 32ºC and 200 RPM in Luria-Bertani 
(LB) broth, supplemented with 100 milligram per liter streptomycin (for all pSRNA 
strains), 35 milligram per liter kanamycin (for all pINT-GA strains), 10 milligram per 
liter tetracycline (for tetracycline resistant BW25113), and/or 34 milligram per liter 
chloramphenicol as appropriate. To test for blue-white screening, morphology of 
antibiotic resistant strains, sRNA-mediated growth arrest, and phenylalanine production, 
relevant strains were cultured at 32ºC and 200 RPM in either LB, M9 minimal media, or 
M9M minimal media, each supplemented with relevant antibiotics as appropriate. A 
complete list of the media recipes may be found in APPENDIX D.   
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Table 2: List of All Strain Names and a Description; 1DH5-alpha was Sourced from 
ThermoFisher, 2BW25113 was Sourced from CGSC, 3NST74 and ZM4 were Sourced 
from ATCC, and all else from This Study. 
Strains Description 
E. coli DH5-alpha1 
dlacZ Delta M15 Delta(lacZYA-argF) U169 recA1 endA1 hsdR17(rK-mK+) 
supE44 thi-1 gyrA96 relA1 
E. coli BW251132 
F-, DE(araD-araB)567, lacZ4787(del)::rrnB-3, LAM-, rph-1, DE(rhaD-
rhaB)568, hsdR514 
E. coli NST743 aroH367, tyrR366, tna-2, lacY5, aroF394(fbr), malT384, pheA101(fbr), pheO352, aroG397(fbr) 
Z. mobilis ZM43 See References44 
E. coli MG1655 K-12 F– λ– ilvG– rfb-50 rph-1 
MG-lacZ E. coli MG1655 pSRNA-lacZ 
BW-cmp E. coli BW25113 pACYC-DUET 
BW-strep E. coli BW25113 pCDF-DUET 
BW-tet E. coli BW25113 pRK415 
BW-dnaE E. coli BW25113 pSRNA-dnaE 
BW-fabB E. coli BW25113 pSRNA-fabB 
BW-fabBH E. coli BW25113 pSRNA-fabBH 
BW-fabD E. coli BW25113 pSRNA-fabD 
BW-fabG E. coli BW25113 pSRNA-fabG 
BW-fabH E. coli BW25113 pSRNA-fabH 
BW-fabI E. coli BW25113 pSRNA-fabI 
BW-folA E. coli BW25113 pSRNA-folA 
BW-folD E. coli BW25113 pSRNA-folD 
BW-folP E. coli BW25113 pSRNA-folP 
BW-murA E. coli BW25113 pSRNA-murA 
BW-rplD E. coli BW25113 pSRNA-rplD 
BW-rplP E. coli BW25113 pSRNA-rplP 
BW-rpsD E. coli BW25113 pSRNA-rpsD 
BW-rpsE E. coli BW25113 pSRNA-rpsE 
pINT-GA E. coli BW25113 pINT-GA 
pINT-GA dnaE E. coli BW25113 pINT-GA pSRNA-dnaE 
pINT-GA fabD E. coli BW25113 pINT-GA pSRNA-fabD 
pINT-GA fabH E. coli BW25113 pINT-GA pSRNA-fabH 
pINT-GA folA E. coli BW25113 pINT-GA pSRNA-folA 
pINT-GA murA E. coli BW25113 pINT-GA pSRNA-murA 
pINT-GA rplD  E. coli BW25113 pINT-GA pSRNA-rplD 
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2.2 Plasmid Construction  
Many plasmids were also used in the course of this study, with some plasmids used only 
intermediately to further construct more complex plasmids; all final plasmids below, 
Table 3: A List of All Plasmids Used in This Study, Their Description and Source. 
Plasmid Description Source 
pKSV45 p15A ori, Ampr, tetR, Ptet 
Prather 
Lab (MIT) 
pACYC-DUET RK2 ori, Cmpr, lacI, PT7 Novagen 
pCDF-DUET cloDF13 ori, Strepr, lacI, PT7 Novagen 
pRK415 oriV, Tetr, Plac Novagen 
pSRNA cloDF13 ori, Strepr, tetR, Ptet This study 
pSRNA-dnaE dnaE target binding sequence inserted into pSRNA This study 
pSRNA-fabB fabB target binding sequence inserted into pSRNA This study 
pSRNA-fabBH fabB and fabH target binding sequence inserted into pSRNA This study 
pSRNA-fabD fabD target binding sequence inserted into pSRNA This study 
pSRNA-fabG fabG target binding sequence inserted into pSRNA This study 
pSRNA-fabH fabH target binding sequence inserted into pSRNA This study 
pSRNA-fabI fabI target binding sequence inserted into pSRNA This study 
pSRNA-folA folA target binding sequence inserted into pSRNA This study 
pSRNA-folD folD target binding sequence inserted into pSRNA This study 
pSRNA-folP folP target binding sequence inserted into pSRNA This study 
pSRNA-lacZ lacZ target binding sequence inserted into pSRNA  This study 
pSRNA-murA murA target binding sequence inserted into pSRNA This study 
pSRNA-rplD rplD target binding sequence inserted into pSRNA This study 
pSRNA-rplP rplP target binding sequence inserted into pSRNA This study 
pSRNA-rpsD rpsD target binding sequence inserted into pSRNA This study 
pSRNA-rpsE rpsE target binding sequence inserted into pSRNA This study 
pgRNA-bacteria ApaLI ori, Ampr, PAmpR 
Qi, et al. 
(2013)45 
pS3 pBR322 ori, Ampr, Plac 
Moore 
(1995) 
pINT-GA(fbr) 
ColE1 ori, Kanr PPDC (PDC Gene Promoter from Z. 
mobilis) aroG15 and pheA101 inserted into BglII and 
XhoI sites.   This study 
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Genomic DNA (gDNA) was prepared using the ZR Fungal/Bacterial DNA MiniPrep™ 
(Zymo Research) according to manufacturer protocols. DNA sequences were PCR 
amplified using a BioRad iCycler system with Q5® High-Fidelity DNA Polymerase 
(NEB) according to manufacturer protocols with custom designed DNA oligonucleotide 
primers (see Table A 1, Appendix B) synthesized by Integrated DNA Technologies 
(Coralville, IA). Amplified linear DNA was purified using the Zymo Research DNA 
Clean & Concentrator™ kit (Zymo Research). Purified DNA fragments and plasmids 
were digested using select restriction endonucleases (NEB) according to manufacturer 
protocols. Digested DNA fragments were separated using gel electrophoresis and purified 
using the Zymoclean™ Gel DNA Recovery kit (Zymo Research) and ligated with T4 
DNA Ligase (NEB) according to manufacturer protocols. Ligation reactions were 
transformed into chemically competent E. coli DH5-alpha and selected for by plating on 
LB solid agar containing antibiotics, as appropriate. Transformant pools were screened 
with the use of colony PCR and confirmed by DNA sequencing.  
Plasmid pKSV45 was a kind gift from Kristala Prather (MIT). 46 Plasmids pCDF-DUET, 
pACYC-DUET, and pRK415 were sourced from Novagen. To construct the pSRNA 
backbone vector, the Strepr-cloDF13 and tetR-Ptet cassettes were PCR amplified from 
pCDF-DUET and pKSV45, respectively, and combined with a custom synthesized sRNA 
scaffold component (GenScript) using circular polymerase extension cloning (CPEC) 
(see Appendix A for complete sequence).41,47 To construct each individual pSRNA vector 
for targeted growth arrest, custom DNA oligonucleotides were synthesized to include the 
target binding sequence unique to each respective gene target. Individual sRNA scaffold 
components were PCR amplified using said primers, and combined using CPEC resulting 
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in the construction of pSRNA-dnaE, pSRN-fabB, pSRNA-fabBH, pSRNA-fabD, 
pSRNA-fabG, pSRNA-fabH, pSRNA-fabI, pSRNA-folA, pSRNA-folD, pSRNA-folP, 
pSRNA-murA, pSRNA-rplD, pSRNA-rplP, pSRNA-rpsD, and pSRNA-rpsE (see 
Appendix B for target binding sequences).  
To ultimately construct pINT-GA, first the intermediate plasmid pINT-Ppdc was 
constructed (not listed in Table 3). To construct pINT-Ppdc, pgRNA-bacteria was 
digested with EcoRI and XhoI to obtain the origin of replication (ColE1) and antibiotic 
resistance (Kanr).45 Then, the promoter for the pyruvate decarboxylase gene (PDC) in Z. 
mobilis ZM4 was PCR amplified and ligated with the digested pgRNA. The plasmid 
pINT-Ppdc contained BglII and XhoI sites after the promoter to allow for BioBrick-like 
insertions. Next, aroG15 was amplified via PCR from pS3 and inserted into the BglII and 
XhoI sites to create pPDC-aroG(fbr). Finally, pheA101 was PCR amplified from the 
genome of NST74 and inserted into the BglII and XhoI sites of pPDC-aroG(fbr) to create 
pPDC-aroGpheA(fbr), otherwise known as pINT-GA(fbr) in this paper. 
2.3 Strain Construction 
E. coli BW25113 was individually transformed with all growth-related sRNA plasmids: 
pSRNA-dnaE, pSRNA-fabB, pSRNA-fabBH, pSRNA-fabD, pSRNA-fabG, pSRNA-
fabH, pSRNA-fabI, pSRNA-folA, pSRNA-folD, pSRNA-folP, pSRNA-murA, pSRNA-
rplD, pSRNA-rplP, pSRNA-rpsD, and pSRNA-rpsE. This resulted in the construction of 
the corresponding fifteen BW25113 strains: BW-dnaE, BW-fabB, BW-fabBH, BW- 
fabD, BW-fabG, BW-fabH, BW-fabI, BW-folA, BW-folD, BW-folP, BW-murA, BW-
rplD, BW-rplP, BW-rpsD, and BW-rpsE.  
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MG1655 was also individually transformed with the plasmid pSRNA-lacZ to target the 
lacZ gene, resulting in MG-lacZ.  
Additionally, to construct the chloramphenicol, streptomycin, and tetracycline resistant 
background BW25113 strains, BW25113 was individually transformed with the plasmids 
pCDF-DUET, pACYC-DUET and pRK415 respectively.  
Finally, to construct the BW25113 strains pINT-GA dnaE, pINT-GA fabD, pINT-GA 
fabH, pINT-GA folA, pINT-pINT murA, and pINT-GA rplD, E. coli BW25113 was co-
transformed with the plasmids pINT-GA(fbr) and pSRNA-dnaE, pSRNA-fabD, pSRNA-
fabH, pSRNA-folA, pSRNA-murA, and pSRNA-rplD, respectively.  
2.4 Protocol for Seed Preparation 
All seeds were inoculated in LB broth, and appropriate antibiotics were added using a 
working concentration of 1 microliter of antibiotics per milliliter of culture and any other 
relevant additives such as x-gal in the case of lacZ gene expression; a final concentration 
of 10 milligrams per liter, 100 milligrams per liter, 34 milligrams per liter, and 35 
milligrams per liter were achieved for tetracycline, streptomycin, chloramphenicol, and 
kanamycin respectively, for relevant antibiotic resistant strains. Seeds for background 
strain BW25113 were prepared from a frozen stock by using a sterile pipette tip to 
introduce a visible amount of bacteria into LB. Seeds for the everything else, which 
contained plasmids, were generated from freshly transformed plates by selecting one 
bacterial colony and introducing it into LB, with appropriate antibiotics added to screen 
for colonies expressing antibiotic resistance. Seeds were incubated in a an automatic 
shaking incubator (Innova 44, New Brunswick Scientific) at 200 RPM and 32 °C for 
approximately twelve hours before use.  
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2.5 Screening Candidate Gene Targets for sRNA-Mediated Growth Arrest 
To investigate potential gene targets for sRNA-mediated growth arrest, relevant strains 
were cultured in LB using 24 or 48 well plates (CytoOne, USA Scientific) with a working 
volume of one milliliter and one half milliliter, respectively. Overnight seed cultures, 
prepared as above, were used to inoculate well plates (1% v/v inoculum) supplemented 
with antibiotics, as appropriate. Well plates incubated in a microplate reader (Multiskan 
Spectrum, Thermo Scientific) for 36 hours at 480 rpm and 32 °C. During the 36 hour 
incubation period, well plate cultures were induced when reaching an optical density at 
600 nm (OD600) of ~0.4, by the addition of 1 mg/mL anhydrous tetracycline (aTc) to 
achieve a concentration of 0.5 μg of aTc per mL of culture. Well plate incubation then 
resumed. In the specific case of MG1655-lacZ and in addition to the relevant antibiotics 
to screen for transformants, 2 microliters per milliliter of 20 milligram per milliliter x-gal 
was added to achieve a concentration of 0.04 milligrams per milliliter for gene 
expression; it is also worth noting that these variants were induced at the start of the 
experiment. 
2.6 Assaying Cell Morphology and Viability 
To investigate the effects of sRNA-mediated growth arrest on cell morphology, relevant 
strains were cultured in M9 minimal media in 24 or 48 well plates (CytoOne, USA 
Scientific) for ~36 hours and imaged using a Zeiss AxioObserver D1 inverted microscope 
(Carl Zeiss MicroImaging Inc.).  To investigate the effects of sRNA-mediated growth 
arrest on cell viability, relevant strains were cultured once more in M9 media, but in a 
shake flask environment. Then before imaging, staining using the LIVE/DEAD BacLight 
Bacteria Viability Kit (Molecular Probes) according to manufacturer protocol was 
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performed at the 42 hour mark. As before, cells were observed using a Zeiss 
AxioObserver D1 inverted microscope (Carl Zeiss MicroImaging Inc.). Sample 
preparation for microscopy analyses consisted of transferring cells (5 microliters) to 25 x 
75 mm glass microscope slides (Santa Cruz Biotechnology), and cover slipping with 18 x 
18 mm glass cover slips (Santa Cruz Biotechnology); the shaker flask experiments 
reached much higher cell densities, so in this case cells were diluted for imaging 
purposes. Microscope images were post-processed and analyzed using ImageJ software, 
where a cell size distribution was generated using the built-in particle analysis tool (see 
Appendix E for protocol).48,49   
2.7 Metabolic Analysis of Contents in Shake Flask Cultures 
Overnight seed cultures were used to inoculate (1% v/v inoculum) 50 mL M9 minimal 
media, containing 20 grams per liter of glucose and appropriate antibiotics. Strains were 
cultured in 250 mL baffled shake flasks at 32ºC and shook at 200 RPM; at an OD600 ~3.0, 
25 microliters of 1 milligram per milliliter aTc was added. Culturing then resumed under 
the same conditions for a total of 72 hours, with periodic sampling for OD600 
measurements and metabolite and catabolite analysis via HPLC, as described below. The 
pH was determined using Hydrion test strips with a range of detection from 4.5 to 7.5 
(Micro Essential Lab) and manually maintained at 6.8 by periodic addition of 0.4 gram 
per milliliter K2HPO4 (Sigma-Aldrich). 
2.8 HPLC Settings for Metabolic Analysis  
Culture samples were first centrifuged at 11,000g for 3 minutes followed by subsequent 
supernatant transfer to glass HPLC vials; all samples were diluted 1:2 with 1 N HCl prior 
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to analysis. Metabolite analysis was performed using a Hewlett Packard 1100 series 
HPLC system. Separation of phenylalanine was achieved using a reverse-phase Hypersil 
Gold aQ C18 column (4.6 x 150 mm; Thermo Fisher) operated at 45ºC with a constant 
flow rate of 0.8 milliliters per minute consisting of 85% 5 mM H2SO4 and 15% 
acetonitrile. The eluent was monitored using a diode array detector (DAD) set at 215 nm. 
Glucose analysis was performed using the same HPLC system equipped with a RID 
detector and an Aminex HPX-87H column (BioRAD, Hercules, CA) operated at 35ºC, 
eluted with a constant flow rate of 0.55 milliliters per minute consisting of 5 mM H2SO4. 
External calibrations were developed and used to quantify each metabolite of interest.  
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3. RESULTS  
3.1 Optical Density Screening Results in BW25113 Strain  
After constructing the BW25113 strain and its variants, initial screening was performed 
in LB broth using a plate reader assay. A list of the names for all the strains used for this 
screening process may be seen in Appendix C, while Appendix F shows the OD600 versus 
time data for the screening process in LB. After gauging the response of the dynamic 
optical density data in LB, the candidates were analyzed in M9 minimal media; the initial 
LB screening served as indication that should the strains not grow in M9 media, it is the 
result of a missing essential nutrient which may be found in LB.  
The proceeding figures detail the results of the plate reader assay in M9 media for all 
BW25113 pSRNA variants. In the screening process, anhydrous tetracycline was added 
to achieve a final concentration of 0.5 micrograms per milliliter, at an OD600 of 
approximately 0.4 to induce the sRNA plasmid early on in the exponential growth phase 
to activate expression; this concentration of anhydrous tetracycline used was shown 
effective to activate gene expression while not influencing the OD600 behavior of 
background strain BW25113 without the sRNA plasmid, as seen in Panel A of Figure 5 
below.  
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Figure 6: The Relationship between OD600 and Time after the Addition of Anhydrous 
Tetracycline (Induced, Red) at an OD600 of 0.4 for BW25113 (Control, Black) and 
pSRNA Variants (Uninduced, Blue) Grown in M9. BW25113, top left; BW-rplD, top 
right; BW-fabB, bottom left; BW-fabD, bottom right. 
As seen in the figure above, fabB was not an effective gene target relative to fabD and 
rplD; while the addition of aTc apparently slowed the exponential growth phase in all 
cases seen above, growth seems to pick back up in the case of fabB and reach the OD600 
of the uninduced and background strain. The growth does not appear to ever reach the 
final value of the control strains in the case of rplD or fabD, though it is interesting to 
note the increased OD600 of the uninduced wild type strain in the case of the fabD gene 
target. In all cases seen in Figure 5 above, the uninduced strain has a similar growth 
profile to the background strain, except in the case of fabB, where the uninduced pSRNA 
variant appears to experience a slight lag in reaching exponential growth phase, but 
otherwise remains the same. It is also worth noting in Figure 5 above that all the strains 
above appeared to grow at the same rate during exponential growth phase and have a 
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similar lag phase. The figure below shows other interesting data, the results of the plate 
reader assay for the fabI, fabG, folA, and folD gene targets, 
 
Figure 7: The Relationship between OD600 and Time after the Addition of Anhydrous 
Tetracycline (I; Induced, Red) at an OD600 of 0.4 for BW25113 (C; Control, Black) and 
pSRNA Variants (U; Uninduced, Blue) Grown in M9. BW-fabI, top left; BW-fabG, top 
right; BW-folA, bottom left; BW-folD, bottom right. 
In the figure seen above, the induced fabI and fabG pSRNA variants never seem to 
experience an immediate cease in growth like the folA and folD variants; furthermore, the 
induced fabG strain in particular does not appear to have significantly diminished the 
OD600. While all four variants above had relatively similar lag phases, the folA and folD 
strains had a fast exponential growth phase indicating they might be good to consider for 
a scale-up application as they may be cultured with greater predictability. Seen below in 
Figure 7 is the relationship for the gene targets folP, murA, rpsD, and rplP, 
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Figure 8: The Relationship between OD600 and Time after the Addition of Anhydrous 
Tetracycline (Induced, Red) at an OD600 of 0.4 for BW25113 (Control, Black) and 
pSRNA Variants (Uninduced, Blue) Grown in M9. BW-folP, top left; BW-murA, top 
right; BW-rpsD, bottom left; BW-rplP, bottom right. 
In the figure seen above, it appears that both folP and rpsD did not have a significant 
reduction on the OD600 relative to the background strain; the murA strain resulted in a 
lower OD600 relative to the background strain, but it is interesting to note that neither 
murA nor rplP had the same immediate cease in growth that folA, folD and even, to a 
degree, folP appeared to show above. All four strains had similar lag phases and growth 
rates during the exponential growth phase; once more it is worth noting the slight overall 
lag associated with the uninduced pSRNA variants, though it does not result in a 
diminished optical density it is consistent across many cases. This could be due to the 
streptomycin resistance putting a burden on the cells, which is further investigated. In 
Figure 8 seen below, the final four gene targets, rpsE, fabBH, dnaE, and fabH are 
explored, 
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Figure 9: The Relationship between OD600 and Time after the Addition of Anhydrous 
Tetracycline (Induced, Red) at an OD600 of 0.4 for BW25113 (Control, Black) and 
pSRNA Variants (Uninduced, Blue) Grown in M9. BW-rpsE, top left; BW-fabBH, top 
right; BW-dnaE, bottom left; BW-fabH, bottom right. 
In the figure above, the first thing to note is once more the shift in growth associated with 
the uninduced pSRNA variant, as was the trend in many cases before. Another thing to 
consider is the similar lag phases and productivity during exponential growth phase, as 
was also a trend seen in earlier pictures. However, the targets fabBH, dnaE, and fabH 
appeared to do a considerable job at stopping growth. The gene target rpsE performed 
relatively well compared to other gene targets such as rpsD and folP as seen in Figure 7. 
Finally, in Figure 9 below, a summary of the OD600 relative to the uninduced background 
strain at the final time point for the induced and uninduced pSRNA variants may be taken 
into consideration, 
  32 
 
 
 
Figure 10: A Comparison of the OD600 Relative to the Uninduced Background Strain 
BW25113 for the Induced and Uninduced pSRNA Variants. 
The bar graph seen above warrants comparison of the large number of candidates in a 
fashion where general trends may be easier to visualize. The black bars seen in the graph 
above represent the uninduced wild-type BW25113 and the respective uninduced pSRNA 
variants, which more or less are within 20% of the uninduced background strain; the 
striped bars represent the induced pSRNA variants, and in the case of these candidates 
there is a diverse response though in general it is clear that growth is suppressed. Some 
candidates such as fabB, fabG, folP, and rpsD did not appear to significantly diminish 
growth, while others such as fabI, folD, and rpsE were more effective, but had interesting 
morphology as will be seen below. The six candidates chosen for phase two of this study 
had effective growth inhibition and interesting morphology changes; these candidates are 
dnaE, fabD, fabH, folA, murA, and rplD. It is interesting to note that all of the genes 
targeted were shown to be essential for viability with the exception of fabH; thoughts on 
potential reasons for the performance observed is summarized in the discussion section.  
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3.2 Morphology Screening Results in BW25113 Strain 
Following each plate reader experiment that occurred in the M9 minimal media using the 
BW25113 pSRNA variants, each well plate was imaged on slides using a microscope; a 
relative size distribution of the cell sizes using the ImageJ automatic particle analysis tool 
was performed to quantify the changes in morphology for each strain (protocol found in 
Appendix E). The images below represent small sections of a larger image which was 
captured at this same resolution; a cut-out essentially, for the purposes of visualization. A 
scaled down version of the larger image would render the cells undistinguishable from 
the background. Seen below in Figure 10 are the morphology results for the background 
strain, in Panel A, and the first three pSNA variants targeting the genes dnaE, fabB, and 
fabBH, as seen in Panels B, C, and D respectively.  
 
Figure 11: Microscopy Images Showing morphology of Uninduced (Left) and Induced 
(Right) Cells for BW25113 pSRNA Variants Grown in M9 at the Final Time Point from 
the Plate Reader Assay; Panel A: BW25113, Panel B: BW-dnaE, Panel C: BW-fabB, 
Panel D: BW-fabBH. 
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It is clear in the case of Panel A from inspection by the naked eye that the morphology of 
the induced cells is not significantly different from that of the uninduced background 
strain when comparing to the changes in morphology observed in panels B, C, and D. In 
the latter panels, the morphology changes are a more evident after induction; the cells 
have a more rod-like, longer profile resulting in a larger size which is visible to the naked 
eye, indicating filamentation occurred to some degree. A similar trend follows suit for the 
rest of the induced strains that have the pSRNA plasmid, indicating the increase in size 
may be a result of anhydrous tetracycline activating the promoter for the afsRNA, or 
possibly the streptomycin resistance; quantifying the relative size change and looking at 
this in combination with the optical density results may elucidate a correlation between 
growth inhibition and increased cell size.  
 
Figure 12: Microscopy Images Showing morphology of Uninduced (Left) and Induced 
(Right) Cells for BW25113 pSRNA Variants Grown in M9 at the Final Time Point from 
the Plate Reader Assay; Panel E: BW-fabD, Panel F: BW-fabG, Panel G: BW-fabH, 
Panel H: BW-fabI. 
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Seen above in Figure 11 are the microscopy pictures for the candidates fabD, fabG, fabH, 
and fabI; it appears in all four cases that the uninduced variants appear to have the same 
smaller morphology as the background strain, indicating the presence of the plasmid may 
not affect the size of the cell when uninduced. The induced variants however show the 
same longer, rod-like morphology seen before. The same may be true for the cases of 
folA, folD, folP, and murA seen below in Figure 12, 
 
Figure 13: Microscopy Images Showing morphology of Uninduced (Left) and Induced 
(Right) Cells for BW25113 pSRNA Variants Grown in M9 at the Final Time Point from 
the Plate Reader Assay; Panel I: BW-folA, Panel J: BW-folD, Panel K: BW-folP, Panel 
L: BW-murA. 
As noted, there is a trend in the morphology between the induced and uninduced variants, 
but this trend is hard to quantify with the naked eye and requires quantification to 
investigate the relationship between the degree of growth suppression and the degree of 
size. While the suppression of growth using the afsRNA seems to go along with an 
increase in cell size, and uninduced afsRNA results in cell sizes equivalent to the 
background strain, the images show that strains in which growth was not significantly 
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suppressed, relative to the uninduced background strain and the uninduced corresponding 
pSRNA variant, still experienced some degree of size increase. While this indicates 
another potential application for the afsRNA – to control cell size without affecting 
optical density and see how the resulting filamentation affects nutrient flux to the cell – 
the degree to which this is possible is outside the scope of this investigation and was not 
further pursued. Nonetheless, as was the case in the figures above, the same morphology 
differences in the induced and uninduced pSRNA variants may be seen below in Figure 
13, 
 
Figure 14: Microscopy Images Showing Morphology of Uninduced (Left) and Induced 
(Right) Cells for BW25113 pSRNA Variants Grown in M9 at the Final Time Point from 
the Plate Reader Assay; Panel M: BW-rplD, Panel N: BW-rplP, Panel O: BW-rpsD, 
Panel P: BW-rpsE. 
In summary, the microscopy pictures show clear changes in morphology after the aTc-
inducible promoter was activated; these morphology changes were quantified using 
ImageJ to determine if activation of the plasmid containing the afsRNA resulted in 
changes to cell morphology. Quantifying these changes in cell morphology enables them 
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to be compared to the changes in optical density to discern important trends in the data. It 
is worth reiterating the protocol used to quantify morphology changes may be found in 
appendix E. The bar graph shown below in Figure 14 represents a similar metric to that 
shown in Figure 9, wherein the relative size change compared to the uninduced 
background strain BW25113 is taken into consideration. This once more allows a nice 
way to summarize the general results for the large number of candidates, 
 
Figure 15: Relative Cell Size for the BW25113 pSRNA Variants With and Without 
Anhydrous Tetracycline Induction; Cells Cultured in M9 Media. 
The morphology changes for most of the pSRNA variants are very robust, indicating for 
cases like folP and fabB that even when optical density was relatively unaffected, 
morphology was still changed. Nonetheless, the uninduced variants for the most part have 
similar cell size relative to the uninduced background strain, while the induced 
background strain shares a nearly identical size with this strain. This filamentation seen in 
the induced variants indicates there might be stress on the cells, and could be a result of 
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the cells trying to increase nutrient flux to mitigate for the suppressed vital gene function; 
the slight filamentation seen in some of the uninduced variants may also suggest that the 
plasmid based approach is stressful to the cell as well. In order to establish a candidate 
selection process for the second phase of this study while also further analyzing the 
relationship between the optical density and cell size, a scatter plot was generated for the 
induced variants which may be seen in Figure 15 below,  
 
Figure 16: A Scatter Plot Illustrating the Relative Size versus the Relative OD for 
Induced pSRNA Variants at the Final Time Point of the Plate Reader Assay 
The figure above shows interesting results as it is now easier to visualize the robust 
morphology changes associated with the induced pSRNA variants, but it also shows the 
large distribution in relative OD600 change. This could imply that even when growth is 
not suppressed, the afsRNA or streptomycin resistance on the plasmid still results in an 
increased cell size; the lack of growth suppression could indicate the gene being targeted 
is not growth essential. This could also mean that when transcription of the targeted gene 
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is inhibited using the afsRNA, it puts a burden on the cell that may be overcome by 
increasing nutrient flux by increasing cell size. As a final possibility, activation of the 
anhydrous tetracycline promoter or streptomycin resistance on the plasmid may 
contribute to the increased cell size independent of the functionality of the sRNA scaffold 
on the plasmid, but this is unlikely because different changes in cell size were seen 
depending on each of the genes being targeted, and targeting different genes requires 
changing the seed region of the sRNA scaffold implying that the gene being targeted by 
the sRNA, at least to some degree, has an effect on the cell size. While any background 
changes in cell size associated with simply activating the aTc promoter would be 
unavoidable using the plasmid-based system at hand, detecting if this is a contributing 
factor may be possible by constructing a strain without the sRNA scaffold but still 
containing the promoter and terminator and gauging the effect on cell size after induction. 
Integrating the plasmid onto the chromosome where it would not need any promoter or 
antibiotic resistance may eliminate any background increases in the cell size. 
Nonetheless, there is a large cluster of candidates encompassing OD600 that ranges from 
75% to 90% of the uninduced background strain, but there are also targets like fabD 
which appear to have a significantly diminished OD600 with a larger cell size, and targets 
like fabB where the cell size is still significantly increased, but the OD600 is nearly the 
same as the uninduced background strain. Based on the optical density results seen in 
Figure 5 through Figure 8, coupled with the microscopy results summarized in Figure 14 
while taking into consideration the mechanism of action associated with each target gene, 
six candidates from this initial pool of sixteen were selected for progression. The six 
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candidates that are further explored in the following sections of the results are BW-dnaE, 
BW-fabD, BW-fabH, BW-folA, BW-murA, and BW-rplD. 
3.3 lacZ and Bacteriostatic Screening Results in BW25113 Strain 
To supplement the results above and gain more insight in regards to the underlying 
mechanism of the sRNA, the strain MG1655 was used to screen the ability of the pSRNA 
plasmid to suppress gene function without inhibiting growth as this strain contains the 
lacZ gene, which enables the cells to metabolize lactose; metabolizing an analogue 
compound of lactose, x-gal, results in the cells expressing a visibly blue phenotype. This 
sheds light on the efficiency of the inducible-sRNA system to block translation of a 
desired gene while also elucidating inherent side effects which may be growth-associated 
as only the metabolism of lactose should be inhibited when the sRNA system is induced 
and growth should otherwise not be affected. These inherent, growth-associated side 
effects that would be obvious in the case of targeting a gene like lacZ would otherwise be 
masked by targeting the growth-essential genes, as their primary purpose is to suppress 
growth anyways. Seen below are the results from the lacZ experiment in MG1655 in M9 
media,  
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Figure 17: The Relationship between OD600 and Time after the Addition of Anhydrous 
Tetracycline (Induced, Red) at an OD600 of 0 for MG1655 (Control, Black) and MG-lacZ 
Variants (Uninduced, Blue) Grown in M9. All Variants, Top Left; Only MG-lacZ 
Results, Top Right; Only MG1655 Results, Bottom Left; Uninduced Comparison, 
Bottom Right. 
It is interesting to note in the figure above the strong variation seen particularly in the 
MG1655 and MG1655-lacZ strain where x-gal was added – the variation in OD600 is 
likely due to the precipitation of the blue product associated with the metabolism of x-
gal. Nonetheless this experiment shows the sRNA does not appear to have much of a 
burden on genes which are not growth essential as there is a relatively unscathed growth 
profile for the induced pSRNA-lacZ variant, though it did keep the cells from turning 
blue.  
In the figure above it may also be seen in the MG1655 and MG-lacZ strain wherein no x-
gal or aTc was added that the strains have a relatively similar growth profile, and overall 
it appears the aTc did not have an effect on the background MG1655 strain at all.  
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Seen below are the resulting microscopy images; it is clear from inspection that the cells 
are all relatively the same size, 
 
Figure 18: Microscopy Images Showing Morphology of MG1655 (Top Row) and MG-
lacZ (Bottom Row) Grown Grown in M9 (Left), with the Addition of x-gal (Middle) and 
with the Addition of x-gal and aTc (Right), at the Final Time Point from the Plate Reader 
Assay. 
The images above show there is not much filamentation present in the induced cells, nor 
in the cells where x-gal was added. It also shows the presence of the pSRNA-lacZ 
plasmid did not result in filamentation as MG-lacZ without x-gal and aTc seemed to have 
a similar morphology as well. The cell sizes were quantified as seen below,  
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Figure 19: Relative Cell Size for the MG1655 pSRNA Variants With and Without x-gal 
and Anhydrous Tetracycline Induction; Cells Cultured in M9 Media. 
It is worth noting that the size difference is very small relative to the uninduced 
background strain for all variants; while the pSRNA-lacZ variant that was induced with 
x-gal and aTc seemed to have the largest change in size, it was not significant and the 
microscopy images show that it did not result in filamentation. This suggests the size 
differences seen were a result of the sRNA targeting growth essential genes. In a similar 
fashion as before, a scatterplot may be seen below in which the relative size and optical 
density are shown in the same graph, 
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Figure 20: A Scatter Plot Illustrating the Relative Size versus the Relative OD for the 
lacZ variants at the Final Time Point of the Plate Reader Assay. 
While this graph reinforces the tight data in which there does not seem to be much of an 
effect of the optical density as a result of targeting the non-growth essential gene lacZ it 
also supports the results from the first phase of the study wherein it was found that the 
filamentation does not have a significant effect on the optical density. It is worth 
considering in this case in particular that the filamentation was not significant in any of 
the cells and the growth was also not suppressed; this suggests the sRNA is responsible 
for growth suppression and that this is a result of targeting growth essential genes.  
To also gauge the inherent effect of the common bacteriostatic additives 
chloramphenicol, tetracycline, and streptomycin in regards to growth suppression and 
morphology, an experiment was conducted wherein these additives were used to suppress 
growth in wild-type BW25113 and the resulting morphology was quantified; in this 
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experiment, a BW25113 strain resistant to each of these bacteriostatic additives was also 
generated to gauge the inherent morphology changes associated with these additives even 
in a scenario where growth should not inhibited. This is insightful as the BW25113 
pSRNA variants all have streptomycin resistance and the pINT-GA pSRNA variants 
additionally have chloramphenicol resistance so it once again may show growth related 
side-effects associated with this plasmid based system; while it appears that the 
morphology of the BW25113 pSRNA variants is unaffected based on the results from the 
uninduced pSRNA variants relative to the uninduced background strain, it is insightful to 
see if this is also the case for chloramphenicol and tetracycline. Seen below is the 
resulting optical density response for the wild-type E. coli BW25113 strain with the 
bacteriostatic additives, and the relevant resistant variants,  
 
Figure 21: The Relationship between OD600 and Time after the Addition of 
Chloramphenicol (Top Left), Streptomycin (Top Right), and Tetracycline (Bottom Left) 
at an OD600 of 0.4 (Bacstat, Red) for BW25113 (Black, Control) and Resistant Strains 
(Blue) Grown in M9. 
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Though it may come as no surprise, the bacteriostatics effectively suppressed growth in 
the wild-type strain while not suppressing growth in the resistant strains. The growth 
suppression associated with the bacteriostatic additives takes effect much more rapidly 
than what was observed with the pSRNA approach, especially in the cases of 
streptomycin and chloramphenicol. In these cases, there is nearly no change in optical 
density once the cells are induced. The dynamic optical density data associated with the 
bacteriostatic resistant strains is also insightful; while there seems to be a delay 
associated with each resistant strain relative to the wild-type BW25113 strain, 
tetracycline has the smallest delay in growth while streptomycin has the largest delay in 
growth. The plasmid-based system used in the pSRNA approach relies on a streptomycin 
resistance, which may have further implications in scale-up approaches as there was a 
consistent lag seen in the growth of this strain relative to the background strain for many 
of the variants. This lag may be a result of the high concentration of streptomycin used in 
the plasmid selection process, 100 mg/L, but it may also be the result of the plasmid 
placing a burden on the cells. Nonetheless, also interesting is the resulting morphology 
from the aforementioned strains; in the microscopy pictures shown below, inspection 
with the naked eye reveals that all the cells appear to be of the same order of magnitude 
in terms of length scale, indicating that minimal filamentation occurs as a result of neither 
the bacteriostatic additives nor the plasmids providing resistance. Filamentation occurs as 
a result of stress on the cell amongst many reasons. Further inspection also reveals that 
chloramphenicol added to the wild-type BW25113 strain seemed to result in no 
morphology changes, with a consistent cell size. The streptomycin had a bit of 
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filamentation occurring, with a mix of cells that were small and large, but it is clear in the 
case of the tetracycline that consistent filamentation occurred.   
                                           
                                      
 
Figure 22: Microscopy Images Showing Morphology BW25113 and Relevant Resistant 
Strains with the Addition of Relevant Antibiotics, Grown in M9. Images Taken at the 
Final Time Point from the Plate Reader Assay.  
Inspecting the BW25113-cmp, BW25113-str, and BW25113-tet strains which contain 
plasmids for resistance to chloramphenicol, streptomycin and tetracycline respectively, it 
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is fairly hard to distinguish any differences in the average cell size relative to the wild-
type BW25113 strain. Seen below is an average cell size of all the cells, normalized to 
the cell size of the wild-type BW25113 strain, 
 
Figure 23: Relative Cell Size for BW25113 with Antibiotics and Antibiotic Resistant 
Strains; Cells Cultured in M9 Media. 
This relative cell size distribution, when coupled with the dynamic optical density data, 
elucidates interesting trends. The BW25113 wild-type strain with tetracycline added took 
the longest to stop growth, and it resulted in the most filamentation amongst the 
bacteriostatic additive based approach; furthermore, the streptomycin-resistant 
BW25113-strep strain also took the longest to reach stationary phase, and it had the most 
filamentation amongst the plasmid-based strains. The filamentation associated with the 
streptomycin resistance may be a contributing background factor in the filamentation 
seen in the BW25113 pSRNA variants. To further gauge the relationship between the 
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optical density and the degree of filamentation, as was explored in the screening of the 
pSRNA system, an analogous scatterplot is presented in the figure below, 
 
Figure 24: A Scatter Plot Illustrating the Relative Size versus the Relative OD for the 
Bacteriostatic Well-Plate Experiment at the Final Time Point. 
In this figure it may be seen that there is once again no clear-cut relationship between the 
degree of growth suppression and the degree of filamentation from the data taken into 
consideration. While this does not suggest the filamentation does not influence the optical 
density measurements, because for the same quantity of cells, longer cells in theory may 
block more light, but this does suggest that the influence may not be straight-forward, or 
may be insignificant. The scatterplot is also useful as it shows the bacteriostatic resistant 
strains all have a similar final optical density relative to the control strain; furthermore, it 
shows that the bacteriostatics all had a very similar effect in growth suppression.  
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3.4 Viability and Metabolic Activity Screening Results in BW25113 Strain  
After selecting the most viable candidates from the first phase of the study based on 
optical density and relative cell size data, scale-up to a working volume of 50 mL for 
culturing the cells was achieved to analyze the cell viability and metabolic activity. 
Scaling up the working volume from microplates to flasks also sheds light on plasmid 
stability. As mentioned in Section 2.8, glucose concentration was analyzed via HPLC.  
Investigating the dynamic glucose consumption for each pSRNA variant may shed light 
into the mechanism by which resources are diverted after inhibiting growth through 
various growth essential gene targets. It is possible glucose consumption may decrease as 
the growth is inhibited, but it is not certain that this will lead to an increase in titer or 
productivity associated with a desirable product with an appropriate pathway 
engineering; it is also possible that glucose consumption may not decrease significantly 
when growth is inhibited, but it is also not certain that this will lead to decreased titer or 
productivity associated with a desirable product under appropriate engineered conditions. 
Ideally the variants should continue to consume glucose at an uninhibited rate after 
induction, mimicking the effect of bacteriostatic additives where only the optical density 
is suppressed but other metabolic functionality remains the same, but these possibilities 
demonstrate the need to characterize the pSRNA variants. Seen below is the data for the 
OD600 and the glucose consumption for the candidates discussed above. Each panel 
contains the strain mentioned in the title, both induced and uninduced; the uninduced 
variants are represented by closed circles and solid lines while the induced are 
represented by the opposite. The left axis represents the OD600, and the right axis 
represents the glucose concentration in grams per liter. The lines representing the OD600 
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are the ones which increase in all cases while the lines representing the glucose 
concentration are the ones which decrease in all cases.  
 
Figure 25: The Relationship between the OD600 (Left Axis), Glucose Concentration 
(Right Axis), and Time after the Addition of Anhydrous Tetracycline (Red) for the 
BW25113 Background Strain and Three pSRNA Variants Grown in M9 Media (Black). 
BW25113, Top Left; BW-dnaE, Top Right; BW-fabD, Bottom Left, BW-fabH, Bottom 
Right.  
As mentioned, the four panels above and the three panels below show the results from the 
50 mL flask cultures; in all cases the glucose concentration decreased with time, and the 
OD600 increased with time as would be expected. It may be seen in the case of the 
background strain that the anhydrous tetracycline had no effect on cells without the 
plasmid in regards to cell growth or metabolic activity; both the optical density and 
glucose consumption is unaffected. In the case of the other six BW25113 mutants, all 
were fairly effective at inhibiting growth in a reasonable amount of time – roughly five 
hours. The growth remained suppressed for the duration of the experiment as well, 
indicating a stable plasmid.  Furthermore, all induced pSRNA variants consumed all the 
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glucose in the time of the experiment, at the same rate as the uninduced background 
strain, resulting in an inherently increased metabolic activity on a cellular level; the 
uninduced pSRNA variants showed a similar metabolic activity to that of the background 
strains considering the similar final cell density and glucose concentration, and as a result 
had a very similar metabolic activity to the background strain.  
 
Figure 26: The Relationship between the OD600 (Left Axis), Glucose Concentration 
(Right Axis), and Time after the Addition of Anhydrous Tetracycline (Red) for Three 
pSRNA Variants (Black) Grown in M9 Media. BW-folA, Top Left; BW-murA, Top 
Right; BW-rplD, Bottom Left.  
To better put the data from the graphs into perspective, quantified below is the specific 
glucose consumption rate, typically in units of 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔
ℎ𝑟𝑟∗𝑘𝑘𝐶𝐶𝑊𝑊𝐸𝐸.𝑔𝑔𝑐𝑐𝑔𝑔𝑖𝑖, for the each of the pSRNA 
variants normalized as a percentage relative to the specific glucose consumption of the 
uninduced background strain, wild-type BW25113. This metric gives insight into how 
much glucose each cell relatively consumes when uninduced and induced,  
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Figure 27: Relative Specific Glucose Consumption Rates ( 𝑔𝑔𝐺𝐺𝑔𝑔𝑔𝑔
ℎ𝑟𝑟∗𝑘𝑘𝐶𝐶𝑊𝑊𝐸𝐸.𝑔𝑔𝑐𝑐𝑔𝑔𝑖𝑖) for the BW25113 
pSRNA Variants Strain at the Final Time Point in Shaker Flask. 
As illustrated graphically, in all cases the induced variants have a higher specific glucose 
consumption than their uninduced counter-parts and the background strain; in the case of 
BW-rplD, the smaller change than the other strains is an inherent result of the higher OD 
at the time of induction, translating to an inherently higher cell density. Though only 
marginally larger than the specific glucose consumption rate of the background strain, it 
is also worth noting the consistently increased specific glucose consumption rate 
associated with the uninduced pSRNA variants. This may be a result of the plasmid 
putting a burden on the cells, but more likely it may be the result of the uninduced 
variants still consuming all the glucose, but at marginally lower optical densities, 
considering the uninduced variants do not appear to affect the cell size. 
Supplementing the dynamic OD600 and glucose concentration data outlined above are 
microscopy pictures showing the morphology of the cells, overlaid with the fluorescent 
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image results from the viability assay, performed at a time of 42 hours. The viability stain 
tags metabolically viable cells as green, and tags non-viable cells as red; fluorescent 
emission may be detected using a blue light to excite the cells stained green, and a green 
light to detect those stained red. It is worth noting that in a similar fashion to the 
microscopy pictures displayed in Figures 10 through 13, these microscopy images are the 
same resolution as the original images taken by the microscope so the morphology of the 
cells may be seen; as a result, the panels above are small segments cropped from the 
much larger images taken by the microscope.     
 
Figure 28: Microscopy Pictures of the Cells Overlaid with Fluorescent Staining Images 
from the Viability Assay Kit Taken at the 42 Hr Mark. Green Staining Indicates Viable 
Cells, and Red Staining Indicates Non-Viable Cells. U Refers to Uninduced, and I Refers 
to Induced Variants of Each Strain. Top Left, BW25113; Bottom Left, BW-dnaE; Top 
Right, BW-fabD; Bottom Right, BW-fabH.  
In almost all cases seen in Figure Figure 252 and Figure 273, nearly every detectable cell 
was viable, and there were almost no detectable non-viable cells; any non-viable cells 
that were detected were included in the images to showcase their characteristics – non-
viable cells may be seen in panels 2I and 5I.     
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Figure 29: Microscopy Pictures of the Cells Overlaid with Fluorescent Staining Images 
from the Viability Assay Kit Taken at the 42 Hr Mark. Green Staining Indicates Viable 
Cells, and Red Staining Indicates Non-Viable Cells. U Refers to Uninduced, and I Refers 
to Induced Variants of Each Strain. Top Left, BW-folA; Bottom Left, BW-murA; Top 
Right, BW-rplD. 
It is also worth noting the morphology of the background strain and the pSRNA variants 
appears representative of the results on the plate reader scale, shown in Figure 14. To get 
a feel for how the metabolic activity in the pSRNA variants compares with common 
bacteriostatic additives that are known to suppress growth while otherwise having a 
minimal effect on metabolic activity, tetracycline, streptomycin, and chloramphenicol in 
concentrations of 10 milligrams per liter, 100 milligrams per liter and 34 milligrams per 
liter were added to the background strain BW25113 in a shaker flask environment. It is 
worth reiterating that BW25113 is a wild type strain and does not have any antibiotic 
resistance; the resulting optical density and dynamic glucose concentrations may be seen 
below in Figure 29,  
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Figure 30: The Relationship between the OD600 (Left Axis), Glucose Concentration 
(Right Axis), and Time after the Addition of Three Different Bacteriostatics – 
Tetracycline (Blue), Streptomycin (Red), and Chloramphenicol (Green). 
As noted, seen above is the dynamic response of the optical density and glucose 
concentration in a shaker flask environment for background strain BW25113 induced 
with three different bacteriostatic additives. While the data above shows the bacteriostatic 
additives seem to have a fast response in regards to growth suppression relative to the 
response of the sRNA-mediated approach, it appears that the metabolic activity was also 
affected relative to the induced pSRNA variants. Seen below is the specific glucose 
consumption rate for BW25113 with the addition of the three bacteriostatic additives, 
relative to the specific glucose consumption rate for wild-type BW25113.  
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Figure 31: Relative Specific glucose Consumption Rates ( 𝑔𝑔𝐺𝐺𝑔𝑔𝑔𝑔
ℎ𝑟𝑟∗𝑘𝑘𝐶𝐶𝑊𝑊𝐸𝐸.𝑔𝑔𝑐𝑐𝑔𝑔𝑖𝑖) for Background 
Strain BW25113 with Bacteriostatic Additives at the Final Time Point in Shaker Flask. 
As mentioned, while the bacteriostatic additives were efficient at suppressing growth in a 
similar amount of time that it took with the sRNA-mediated approach, the specific 
glucose consumption rate did not appear to increase as significantly relative to the sRNA-
mediated approach. Referring back to Figure 29 above, this is likely a result of the fact 
that not all the glucose was consumed in the case of the strains with bacteriostatic 
additives. Especially in the case of chloramphenicol addition it appears that a significant 
amount of glucose was left over, indicating that metabolic activity was diminished; a 
result not observed with the sRNA approach.  
To further gauge the metabolic activity of the cells, a fed-batch culture was grown using 
the BW25113 pSRNA-murA variant to determine if the induced cells remained 
metabolically active over a longer period; this may shed insight into the potential for the 
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variants to convert resources into desirable products. The pSRNA-murA variant was 
chosen for its effective OD repression, good specific glucose consumption rate and vivid 
viability stain results. In the fed batch experiment, BW25113 and the pSRNA-murA 
variant were both grown in M9 minimal media; once more induction occurred in the mid-
exponential phase. This time however, a charge of the dextrose, ammonium chloride, 
magnesium sulfate and calcium chloride were added. The amount of dextrose fed, 0.5 
grams added to the 50 mL culture, is half of what was initially present in the fresh M9 
media; the amounts of ammonium chloride, 0.05 grams, magnesium sulfate, 0.1 mol, and 
calcium chloride, 0.005 mol, fed are equivalent to the amount originally in a fresh 50 mL 
flask of M9 media. The charge of nutrients was added to prolong the exponential phase, 
increasing the total cell density of the culture – this inherently means the feed must be 
added during exponential phase. Seen below are the resulting optical density and 
metabolite analyses for the fed batch experiment,  
 
Figure 32: The Relationship between the OD600 (Left Axis), Glucose Concentration 
(Right Axis), and Time after the Addition of Anhydrous Tetracycline (Red) to BW25113 
and BW-murA (Black) in the Fed-Batch Experiment.  
  59 
 
 
As shown in the figure above, the feed was added at the 15 hour mark, during the later 
end of the exponential growth phase; this was added to bring the total concentration of 
glucose back to roughly 20 grams per liter. Seen in the graph on the left, it appears that 
the aTc-induced wild type BW25113 did not experience any significant change in either 
glucose consumption rate or in final optical density, but looking at the optical density and 
glucose consumption rate versus time in the graph on the right, it appears that the aTc-
induced pSRNA-murA variant never achieved the same final optical density as the 
uninduced variant, while still consuming glucose. These results parallel the results from 
the shaker-flask experiment seen above, while indicating that the induced sRNA variant 
is able to continue consuming glucose. Seen below is the specific glucose consumption 
rate of the wild-type BW25113 strain with the addition of aTc, and the pSRNA-murA 
variant, both induced and uninduced, relative to the uninduced wild-type BW25113 
strain, 
 
Figure 33: Relative Specific Glucose Consumption Rates ( 𝑔𝑔𝐺𝐺𝑔𝑔𝑔𝑔
ℎ𝑟𝑟∗𝑘𝑘𝐶𝐶𝑊𝑊𝐸𝐸.𝑔𝑔𝑐𝑐𝑔𝑔𝑖𝑖) for the BW-murA 
Variant in a Fed Batch Environment. 
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As mentioned, the figure above shows the relative glucose consumption rate for the 
pSRNA-murA variant. While the addition of aTc did not seem to have any effect on the 
optical density or dynamic glucose concentration in the background BW25113 strain in 
the fed-batch environment, the induced pSRNA-murA variant did have an increased 
relative specific glucose consumption rate while its uninduced counterpart did not. In 
correspondence with the figure showing optical density and glucose concentration as a 
function of time, this is due to the fact that the induced sRNA variant continues to 
consume glucose even when growth is suppressed. Nonetheless, the increase in the 
specific glucose consumption rate in the fed-batch environment appears to be lower than 
the increase seen in the pSRNA-murA variant that was not fed, as shown in Figure 26; 
these results appear to be closer to the effect seen by the bacteriostatic additive 
suggesting in a long-term culture that the plasmid-based system may not be able to 
generate a consistent biosynthesis product. Though further discussed in the results 
section, this could be a result of the increased optical density seen in the fed-batch 
experiment. Nonetheless, these results indicate that the sRNA is effective at suppressing 
growth without having a significant effect on cell viability or metabolic activity, unlike 
the bacteriostatic additives.  
3.5 Phenylalanine Production Optimization in BW25113 pINT-GA and pSRNA Variants  
To supplement the results above which appear to show that the sRNA plasmid is effective 
at suppressing growth without affecting either the viability or metabolic activity of the 
cells, the sRNA plasmids corresponding to the same 6 gene candidates, dnaE, fabD, 
fabH, folA, murA, and rplD, were transformed into the phenylalanine overproducer 
BW25113 pINT-GA, which has a feedback resistant copy of the genes aroG and pheA 
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overexpressed as discussed further in the strain construction section of Materials And 
Methods. The capability of the pINT-GA strain coupled with the pSRNA plasmid to 
solely suppress growth was first screened in a plate reader experiment – the results of 
which may be seen below,  
 
Figure 34: The Relationship between OD600 and Time after the Addition of Anhydrous 
Tetracycline (Red) at an OD600 of 0.4 for pINT-GA pSRNA Variants (Blue) Grown in 
M9M. pINT-GA, top left; pINT-GA dnaE, top right; pINT-GA fabD, bottom left; pINT-
GA fabH, bottom right. 
As noted, seen in the figures above and below, the pINT-GA strain and the pSRNA 
variants were run in a plate reader assay to screen the efficacy of growth suppression in 
the induced strains; the first panel in the figure above shows that the concentration of 
anhydrous tetracycline slightly slows the growth in the exponential phase of the pINT-
GA strain which has no sRNA plasmid, and results in a marginally lowered optical 
density in the plate reader assay. While the effects of growth suppression are more robust 
in the strains with the sRNA plasmids, as expected, some of these strains ultimately 
reached an optical density close to the uninduced counterpart and the control strain, 
though it took much longer. Nonetheless, this indicates there may be interference 
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between using these two plasmids in conjunction with one another. While the dnaE 
variant very nearly reaches the uninduced optical density, fabD, folA and rplD seem to be 
rowing at a rate which could also reach the same optical density; nonetheless, in all four 
of these cases the exponential growth phase is significantly slowed down indicating the 
pSRNA plasmid is having some type of significant effect on targeting growth associated 
genes. These results differ from the observed behavior of the pSRNA variants in wild-
type BW25113, which did not contain the pINT-GA plasmid. Nonetheless, the fabH 
variant and the murA variant exhibit the best growth suppression of the pINT-GA 
pSRNA strains, though it is worth noting in both cases there seems to be a shift in the 
overall growth, with fabH being more drastic than murA.  
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Figure 35: The Relationship between OD600 and Time after the Addition of Anhydrous 
Tetracycline (Red) at an OD600 of 0.4 for pINT-GA pSRNA Variants (Blue) Grown in 
M9M. pINT-GA folA, top left; pINT-GA murA, top right; pINT-GA rplD, bottom left. 
Ultimately it appears as if the sRNA was more stable in the wild-type BW25113 strain 
than in the pINT-GA variant, as none of the growth suppression appeared to be as 
effective as it did in the background BW25113 strain. To gain further insight in regards to 
the morphology of the pINT-GA pSRNA strains which were screened in the plate reader 
experiment above, the cells at the final time point were imaged; these images may be 
seen below,   
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Figure 36: Microscopy Images Showing morphology of Uninduced (Left) and Induced 
(Right) Cells for pINT-GA pSRNA Variants Grown in M9M at the Final Time Point 
from the Plate Reader Assay; Panel 1: pINT-GA, Panel 2: pINT-GA dnaE, Panel 3: 
pINT-GA fabD, Panel 4: pINT-GA fabH. 
As mentioned, the images above and below show the morphology of the pINT-GA 
background strain (Panel 1), and the pSRNA variants (Panels 2-7), both uninduced and 
induced at the final time point of 37 hours. The first thing to notice in these images is that 
once more the induced pSRNA variants take on a much longer, rod-shaped morphology, 
which again may be a result of trying to increase nutrient flux into the cell. In the case of 
the pINT-GA pSRNA induced variants, the filamentation that occurred was much more 
robust than observed in the pSRNA variants in the wild-type BW25113 strain. 
Furthermore, there appears to be a less consistent cell size amongst the induced pINT-GA 
pSRNA variants, especially in the case of the fabD gene target which blocks fatty acid 
biosynthesis. In the wild-type BW25113 strain, all the induced cells appeared to be 
elongated, but in the pINT-GA variant, there was a mixture of some elongated cells and 
some cells close to the size of the background pINT-GA strain. While it may seem 
plausible that the similar final optical density of the background strain and the induced 
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and uninduced pSRNA variants in cases like fabD could be due to the different 
morphologies observed, suggesting not all of the cells were affected equally by the sRNA 
plasmid, the case of dnaE as seen in Figure 2 seems to refute this observation. In the case 
of dnaE in particular, the most elongated cell morphology was observed with the average 
cell roughly 300% bigger than the uninduced background strain, however even in this 
case the cells reach nearly the same final optical density as the uninduced counter-part 
and the background strain. Furthermore, in one of the cases with the best growth 
suppression, fabH, the morphology was only 200% of the background strain; 
furthermore, in this particular case, it appears that the uninduced fabH pSRNA variant 
had nearly the same morphology as the induced variant, even to the naked eye as seen in 
Panel 4. Nonetheless, it is also apparent in this image that the cell density of the induced 
variant is much less than the uninduced variant.    
 
 
Figure 37: Microscopy Images Showing morphology of Uninduced (Left) and Induced 
(Right) Cells for pINT-GA pSRNA Variants Grown in M9M at the Final Time Point 
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from the Plate Reader Assay; Panel 1: pINT-GA folA, Panel 2: pINT-GA murA, Panel 3: 
pINT-GA rplD. 
It is also interesting to examine in more detail the case of the gene target murA, which 
had effective optical density suppression as well as an increased cell size. This ultimately 
means there is no direct correlation to the enhanced cell size and effective optical density 
suppression; to summarize, dnaE had the largest morphology with ineffective growth 
suppression, while fabH and murA had effective growth suppression, but drastically 
different morphologies. This may indicate the morphology in the case of the pINT-GA 
strain is more sensitive to the selected gene target than in the case of wild-type 
BW25113. One final thing to note, and perhaps best visualized by the figure below which 
summarizes the cell size relative to the uninduced background strain, BW25113 pINT-
GA, is the increased cell size of all the uninduced pSRNA variants, even though the 
induced pINT-GA variant does not have a significantly increased cell size.  
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Figure 38: Relative Cell Size for the pINT-GA pSRNA Variants With and Without 
Anhydrous Tetracycline Induction; Cells Cultured in M9M Media. 
As expressed above, the morphology changes in the BW25113 pINT-GA pSRNA 
variants suggests this may be a result of the gene targeted, and may be unrelated to the 
growth suppression; this is supported by considering the two genes responsible for fatty 
acid biosynthesis, fabD and fabH, were also the two genes that resulted in the smallest 
morphology changes. While the results of the growth suppression in the pINT-GA strain 
do not look as effective as they did in the background BW25113 strain, and the 
morphology changes do not see to be consistent with the wild-type BW25113 strain, this 
could be a result of the plasmid-based approach rather than integrating everything onto 
the chromosome of BW25113. To once more investigate the relationship regarding the 
degree of filamentation, which may be represented by the relative size change, with 
respect to the degree of growth suppression, represented by the relative final optical 
density, a scatter plot was constructed which may be seen in the figure below, 
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Figure 39: A Scatter Plot Illustrating the Relative Size versus the Relative OD for the 
pINT-GA Well-Plate Experiment at the Final Time Point 
It appears in the figure above that there is not a clear relationship between any degree of 
filamentation resulting in any degree of growth suppression in either the induced variants 
or the uninduced variants. In the case of the uninduced variants this scatterplot makes it a 
bit easier to visualize that while the growth did not seem to be suppressed in any of the 
cases, they did seem to experience different degrees of filamentation. In the induced 
variants, growth was suppressed to different degrees, and while this has been shown to be 
a result of the gene targeted by the pSRNA system, once more it does not seem that there 
is any discernable background contribution in optical density due to filamentation. While 
this is not to say the filamentation is not having an influence on the optical density, more 
rigorous experiments are needed to further investigate this relationship to determine if it 
exists and to what degree.  
  69 
 
 
Nonetheless, to examine the metabolic activity of the pINT-GA strain, the murA variant 
was once more selected based on its effective growth suppression and moderate 
morphology results. Using the pINT-GA pSRNA-murA strain, the dynamic optical 
density, glucose consumption rate, acetate production, and phenylalanine production was 
measured in the span of 70 hours, as summarized in the figures below, 
 
Figure 40: The Relationship between the OD600 (Left Axis), Glucose Concentration 
(Right Axis), and Time after the Addition of Anhydrous Tetracycline to pINT-GA (Left 
Graph) and the pINT-GA murA Variant (Right Graph) at Two Time Points (T1, Blue and 
T2, Red). 
The figure above illustrates the dynamic optical density and glucose concentration as a 
function of time; there are many things to note in the figure above, but perhaps the most 
obvious is first that the marginally slower growth seen in the induced background pINT-
GA strain in plate reader was not observed in the scaled-up shaker flask, and second that 
in all the cases the glucose is fully consumed in relatively the same amount of time. By 
the 50 hour mark, there appears to be no glucose left and the rate at which it was 
consumed is consistent across all strains. Another obvious thing to note is the increased 
optical density of all the strains, relative to the background BW25113 strain; these strains 
all grow to a higher optical density indicating the presence of the pINT-GA plasmid 
increases nutrient flux towards biomass synthesis. Even more interesting is the fact that 
the uninduced strain with two plasmids, pINT-GA murA, achieves a higher optical 
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density than the strain with one plasmid, pINT-GA, though in the plate reader screening 
experiment the murA variant did not achieve a higher optical density; this suggests that 
the effects of the pINT-GA plasmid is compounded by the sRNA plasmid in regards to 
reallocating resources to synthesizing more biomass. This is, unfortunately, the opposite 
of the ultimate goal. Also seen in the figure above, inducing pSRNA-murA variant at the 
two different time points during the exponential phase, first at the 14 hour mark and 
second at the 17 hour mark, did not seem to ultimately affect the final optical density, 
though it did appear to affect the final concentration of phenylalanine. The dynamic 
phenylalanine data may be seen below,  
 
Figure 41: The Relationship between Phenylalanine Production and Time After the 
Addition of Anhydrous Tetracycline to BW25113-pINT-GA (Left Graph) and the 
pSRNA-murA Variant (Right Graph) At Two Different Time Points (T1 Blue, T2 Red). 
The dynamic phenylalanine data is interesting because it shows that almost all of the 
phenylalanine produced was during the exponential phase, especially in the case of the 
pINT-GA murA variant. Examining the pINT-GA strain without the sRNA plasmid in 
more depth, it appears that both ultimately reach the same final concentration of 
phenylalanine. They appear to make it at the same rate as well, though paying notice to 
the insignificantly higher phenylalanine near the 35 hour mark, which appears to be 
consumed by the cells. This suggests that the aTc had no effect on the production of 
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phenylalanine in the background pINT-GA strain; in the case of the pSRNA-murA 
variant, the effect of the aTc is interesting. It appears in the uninduced strain that some of 
the phenylalanine was reuptaken by the cells, before ultimately being regenerated, and 
the same may be said but less pronounced with regards to the set induced at the first time 
point. However, the pSRNA-murA variant induced at the second time point did not 
appear to reuptake any phenylalanine, though it did appear to make most of the 
phenylalanine during the exponential phase, as was the case observed across the board. 
While the dynamic phenylalanine production data suggests phenylalanine production is 
tied closely to growth. While it is possible to generate a higher titer of phenylalanine by 
picking the right time point, as observed in case 2 where the final concentration is higher 
than the uninduced strain, it also suggests that the timing is very sensitive, as the first 
case generated less phenylalanine. Furthermore, the fact that all of the pSRNA variants 
did not generate as much phenylalanine as the background pINT-GA strain, the results 
suggest using there are conflicts with using this plasmid-based system, as it was also 
observed that the pSRNA variants had a higher optical density.  
In environmental conditions with excess glucose, glucose may be directly converted to 
acetate; monitoring the production of acetate serves as a good indication for the ability of 
the cell to convert glucose into the desired product but also a good indication of stress on 
the cell. Seen in the figure below is the dynamic acetate production, 
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Figure 42: The Relationship between Acetate Production and Time After the Addition of 
Anhydrous Tetracycline to BW25113-pINT-GA (Left Graph) and the pSRNA-murA 
Variant (Right Graph). 
Looking at the dynamic acetate production above, it is clear that the pSRNA variants do 
not make nearly as much acetate as the background pINT-GA strain; this has potential to 
be beneficial as it may reroute the excess glucose into phenylalanine, but unfortunately as 
summarized best in the figures below it would appear that the excess glucose, rather than 
being converted towards acetate or phenylalanine, is used towards biomass synthesis, 
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Figure 43: The Final Phenylalanine Concentration (Top Left), Gram of Phenylalanine per 
Gram of Glucose (Top Right), Gram of Phenylalanine per Gram of Cell Mass (Bottom 
Left), and Gram of Cell Mass per Gram of Glucose (Bottom Right) for the BW25113 
pINT-GA and pSRNA-murA Variant.  
The figures seen above indicate that, in general, the plasmid-based pSRNA approach was 
ineffective, and actually counterproductive, when coupled with the plasmid-based 
approach to overexpress the genes responsible for phenylalanine synthesis. In terms of 
final titer, the pINT-GA strain lacking the plasmid based pSRNA system performed best, 
and it was found that the pINT-GA murA variant induced at the second time point was 
the second best. The first time point of induction actually made less than the uninduced 
pSRNA variant. These results indicate the timing is very sensitive in regards to 
decoupling the production from growth, but it is possible – though plasmid compatibility 
or a plasmid based approach may be problematic. Looking next at the grams of 
phenylalanine per grams of glucose, it is also seen that the pINT-GA strain lacking the 
pSRNA system performed best; this indicates that the either more of the glucose was 
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used to make phenylalanine, or the phenylalanine was more efficiently made. 
Nonetheless, the same trend in regards to the pSRNA system that was seen in the case of 
titer is also seen in the case of phenylalanine yield with respect to glucose, wherein the 
second time point of induction performed best and the first time point of induction 
performed worst.  Further In terms of yield of phenylalanine with respect to cell mass 
however, the first time point of induction was shown to be a bit better than the uninduced 
variant, indicating there is some sort of increased metabolic activity at this induction time 
for less cells to be able to make the same total concentration of phenylalanine. The grams 
of cell mass per grams of glucose provide more insight into how the glucose is being 
used; it is seen that the pINT-GA lacking the plasmid based system seems to exhaust 
significantly less glucose making cell mass then the uninduced pSRNA variant, 
indicating there is an increased flux towards biosynthesis in the double-plasmid system. 
Unfortunately, even though a relatively similar amount of glucose made a relatively 
similar amount of cell mass between the pINT-GA strain lacking the pSRNA system and 
the induced pSRNA variants, this did not scale to equal amounts of phenylalanine being 
produced. This indicates that in this plasmid based approach, while the sRNA does seem 
to increase relative efficiency, this system in particular puts a burden on the cell which 
makes it generate less phenylalanine than it would have if the plasmid were not present in 
the first place, and it is clear that it is losing glucose to some other mechanism aside from 
biomass synthesis that is not present in the strain that does not contain both the pINT-GA 
plasmid and the pSRNA plasmid.  
In conclusion, while there is an interference between the two plasmids used in this 
particular case it still appears as if the pSRNA approach is effective at increasing the flux 
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of nutrients towards the production of phenylalanine, even considering how closely to 
growth phenylalanine production is tied. This proof-of-concept opens the door to further 
insight regarding more efficient ways to implement the afsRNA system generated with 
the purpose of metabolic engineering in mind.  
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4. DISCUSSION 
4.1 Optical Density and Morphology Screening Discussion in BW25113 Strain  
In the first phase of the experiment, the coding sequence corresponding to the target 
binding site for each of the potential gene targets was placed in the seed region of the 
modular synthetic afsRNA scaffold, which was then placed on a plasmid with the 
anhydrous tetracycline promoter and the T1/TE terminator as well as streptomycin 
resistance; this was effectively transformed into the background strain BW25113 and the 
OD600 and morphology of the cells were screened in nutrient rich LB media and M9 
minimal media. Screening in LB before moving to M9 media warrants insight into 
nutrient deficiencies; a strain which grows in LB but not M9 may lack essential nutrients, 
whereas a strain that does not grow even in LB may be experiencing other problems. 
Nonetheless, a concentration of 0.5 μg of aTc per mL of culture was used in this study as 
it showed effective expression of the sRNA plasmid without affecting any metabolic 
functionality of the background strains that did not have the aTc inducible promoter; in 
another study using an aTc inducible promoter, aTc concentrations ranging from 1 to 10 
ng per mL of culture were shown effective, a concentration orders of magnitude less than 
what is used in this study.50 This implies that it may be possible to improve the affinity of 
aTc to bind with the promoter resulting in less aTc necessary; on an industrial scale this 
may result in significant cost reduction.  
Aside from the growth essential genes which were targeted, an additional sRNA plasmid 
which targets the lacZ gene found on the chromosome of MG1655 to further characterize 
the underlying mechanism regarding how the sRNA suppresses growth. This was a useful 
experiment because cells which express the lacZ gene may consume x-galactose and as a 
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result may turn blue, but also because lacZ is a gene known to be unassociated with 
growth.51 This experiment ultimately shows that the suppression of growth observed in 
other strains is likely a result of inhibited gene translation, as the MG1655 variant which 
expressed the lacZ gene without the lacZ sRNA plasmid did turn blue after being fed x-
galactose, as expected. Furthermore, the MG1655 variant expressing the lacZ gene and 
containing the lacZ sRNA plasmid without the addition of aTc also turned blue in the 
presence of x-galactose, also expected because the psRNA was not induced and therefore 
should not disrupt translation. However, adding anhydrous tetracycline (aTc) to this 
variant, resulting in the expression of the lacZ sRNA plasmid, resulted in less blue cells 
with a relatively unscathed growth profile indicating it was successful at targeting the 
gene lacZ which is essential for the blue phenotype while not otherwise affecting 
metabolic activity of the cells. .  
These results suggest that the addition of the aTc warrants expression of the lacZ sRNA 
plasmid, resulting in inhibition of only the lacZ gene expression with no observable effect 
on growth. This result concludes that the seed region in the sRNA plasmid must be 
responsible for the effects observed, considering the only factor changed amongst the 
various strains is the coding sequence in this region. This then suggests that the relatively 
different optical density differences may be a direct reflection of the efficacy in which the 
sRNA was able to suppress growth by inhibiting the transcription of potentially growth 
essential genes; this was assumed to be the case and the response of each gene in regards 
to growth suppression was used to make the decision regarding which targets to 
transform into the phenylalanine overproducer, pINT-GA. Making sense of the 
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responses, the pathways corresponding to the genes of interest and how this might relate 
to the results observed is discussed below.   
To supplement this discussion, it is interesting to note the coupled changes in 
morphology that simultaneously occurred with the activation of the sRNA plasmid; while 
the induced background strain and all of the uninduced pSRNA variants did not show 
much of a size difference relative to the uninduced background strain, all of the induced 
variants with the exception of fabI showed relatively large increases in cell size. It is also 
worth noting fabI did not show good growth suppression either indicating it may have 
been ineffective at targeting growth, but also indicating the mechanism of action does not 
result in filamentation. The data from this experiment, summarized in Figure 15, suggests 
there is no significant, straight-forward correlation between background increases in 
optical density as a result of filamentation, though not to say this is not present. 
Considering the differences in the relative cell size, and once more considering the only 
thing changing is the seed region of the sRNA scaffold, the target gene once more must 
be directly responsible for the observed effect on cell size. One interesting trend to note is 
the observation that suppression of growth lead to an increase in cell size relative to the 
uninduced variants when the pSRNA targeted growth essential genes; perhaps targeting 
essential genes at a mid-exponential time point can cause an increase in cell size to 
possibly increase nutrient flux, as the change in cell size was only seen in the induction of 
essential genes and not so much in the lacZ experiment. This suggests that the pSRNA 
does not affect the background optical density, when induced and not targeting growth 
essential genes.  
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For example, in the case of the genes fabB and fabH, it was found that inhibiting fabB did 
not have much of an effect on OD suppression while blocking fabH significantly 
suppressed the optical density, as summarized in Figure 9. This is particularly interesting 
because fabB has been shown to be growth essential and blocks a critical step in the 
overall fatty acid biosynthesis I pathway, while fabH has been shown to be non-essential 
for growth, but this was only shown in knock-out strains and not in a strain that 
dynamically suppresses gene expression.52 Nonetheless, consider the interaction between 
fabB and fabH in the synthesis of an acetoacetyl-(acp) from acetyl-CoA, as summarized 
in the figure below,53 
 
Figure 44: The Synthesis of an acetoacetyl-(acp) from acetyl-CoA in the Fatty Acid 
Biosynthesis Pathway Manifesting the Redundancy of the Presence of fabB and fabH.53 
In the figure above, blocking fabB still warrants the formation of an acetoacetyl-(acp) 
from acetyl CoA as a route involving the fabH gene exist, and the same may be said in 
regards to inhibiting fabH (though in the case of fabB, it blocks a step later down the line 
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which there are no alternate pathways in which to circumnavigate).52 However, one 
possible explanation for the data observed, where fabH was shown a more effective gene 
target than fabB in regards to growth suppression, may be due to the fact that blocking 
fabH makes the process much more energetically intensive to overcome than blocking 
fabB, relating back to the concept of kinetics versus thermodynamics that was discussed 
in the introduction.  
The synthesis of an acetoaetyl-(acp) from acetyl-CoA without the fabB gene, but with the 
fabH gene, results in the formation of two intermediates – malonyl-CoA and a malonyl-
(acp). The same synthesis, but now blocking the fabH gene and keeping the fabB gene 
requires the synthesis of four intermediates – malonyl-CoA, a malonyl-(acp), an acetyl-
(acp), and acetoacetyl-(acp) synthase – and in the case of fabB inhibition, a malonyl-(acp) 
may be directly converted to an acetoacetyl-(acp), ending the process a step early.52 
Therefore it is possible that the burden put on the cell by blocking the fabH gene renders 
fatty acid biosynthesis not possible, likely because not enough acetoacetyl-acp is ever 
formed to carry the process forward. Considering this behavior was not seen in the 
knock-out strains generated in literature, the presence of growth of the pSRNA-fabB 
variant coupled with the effective suppression of growth in the pSRNA-fabH variant may 
be a result of the fact that this is different from a knock-out in the sense that it occurred at 
an optical density of ~0.4 and gave the cells time to grow and form intermediates. The 
increased optical density, resulting in an increase cell concentration, may have enabled 
build-up of intermediates which enabled the fabB variant to sustain while the fabH 
variant was not.  
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In any case, while the pathway governing the synthesis of an acetoacetyl-(acp) from 
acetyl-CoA warrants possible insight into the dynamic functionality of fabB and fabH and 
the general behavior of growth essential genes with dynamically suppressed expression, 
the corresponding morphology changes also offer an interesting take on things.52 It may 
be observed that in both the case of pSRNA-fabB and pSRNA-fabH induction resulted in 
filamentation. Although growth was not suppressed with respect to fabB, it was 
suppressed to fabH; one possible reason for filamentation is that the cell increases its 
surface area to increase the nutrient flux to mitigate for the diminished gene activity. In 
the case of targeting fabB, it is possible that by increasing its size the cell was able to 
uptake enough nutrients to maintain viability; this is not to rule out the possibility that 
inherent activation of the pSRNA plasmid, when acting on a valid gene, results in a 
general background increase in size, though this was not the case in the pSRNA-lacZ 
analysis.  
To further investigate the relationship between fabB and fabH and the stability of the 
pSRNA system at targeting more than one gene, a combination double-sRNA-scaffold 
plasmid strain was constructed, targeting both fabB and fabH, and referred to as fabBH; 
the results of this strain were nearly identical to the results observed in fabH in regards to 
both optical density and morphology, indicating effective suppression of growth. 
Construction of this strain would ensure that the literature-proven growth essential fabB 
gene would be targeted in addition to the fabH gene which was shown to suppress 
growth. However, when constructing the phenylalanine overproducer only the plasmid 
containing the fabH gene target was transformed into the cell as three plasmids puts 
significantly more of a burden on the cell than two plasmids. This is a trade-off as it has 
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been verified in literature that fabB is essential for viability and fabH is not, but the 
results observed in this investigation are opposite.   
Further examining the behavior of growth suppression observed for each of the pSRNA 
variants grown in M9 minimal media, dnaE was seen to suppress growth effectively, 
reaching stationary phase at the same time as the uninduced background strain, with the 
uninduced dnaE showing a relatively similar size and optical density as the background 
strain. Compared to the bacteriostatic additives, the pSRNA-dnaE variant took much 
longer to take effect, and it also had a much higher degree of filamentation. This may be 
indicative that the plasmid put a stress on the cell, and perhaps the cell attempted to 
mitigate for the lack of essentiality by increasing nutrient flux; if this were the case it may 
be plausible the filamentation occurred during the lag between induction and stationary 
phase – the “pseudo-exponential” phase seen after induction – wherein the cell increases 
in size to “fight the plasmid” and remain viable, but ultimately fails. If this is the case it 
would suggest that a faster-acting system, one with a comparable speed to the 
bacteriostatic additives, may leave cell morphology unchanged. Nonetheless, the viability 
results make sense as dnaE has been shown to be a growth essential gene and appears to 
have been successfully targeted with the plasmid-based sRNA system.52 The same 
conclusions can be said in regards to fabD, fabI, folA, murA, rplD, rplP, and rpsE – these 
are all growth essential gene that were shown to suppress growth when induced in the 
mid-exponential phase and these all resulted in an increased size. It may be assumed that 
the mechanism of action by which growth was suppressed for the aforementioned 
candidates is a result of a lack of functionality due to the inhibited translation of the target 
gene, as all of their uninduced variants did not show a suppressed optical density.  
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In the case of the pSRNA-fabD variant, since growth was not observed it is likely that the 
sRNA blocked the translation of the fabD gene which ultimately blocked the formation of 
a malonyl-(acp) from a malonyl-CoA; this step, as seen in Figure 43 above is essential for 
the formation of an aetoacetyl-(acp) and cannot be circumnavigated.52 Nonetheless, 
further examining the results of the fabD optical density data shown in Figure 5 there is 
still a delay for the suppression to fully take effect, and filamentation seems to be just as 
drastic as gene targets which are not associated with fatty acid biosynthesis. Once more 
this indicates that improving the response of the system to make it suppress growth more 
rapidly after induction may mitigate these morphology changes. This is a hard judgement 
to make though, as the other fatty-acid biosynthesis gene explored, fabI, seemed to be 
relatively ineffective at inhibiting growth, but also experienced the least filamentation out 
of everything. The lack of filamentation suggests the cell may not have been under as 
much stress as in the case where other genes were inhibited, but the lack of rapid growth 
suppression indicates the sRNA approach was also not as effective in regards to this gene 
target. Considering fabI has been shown to be a growth-essential gene, more work should 
be done in regards to this gene target to further explore its efficacy in an sRNA-mediated 
approach if it is found that this would be an optimal gene to inhibit for reasons of 
conflicting pathways with other genes explored in this study.52 Whereas fabD is only 
involved in one reaction, fabI is involved in 15 known reactions within E. coli, so in both 
cases it is possible that the build-up of intermediates in the time before induction 
occurred resulted in a while for the growth to be suppressed as first these intermediates 
had to be exhausted.52  
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However, it is interesting to note that, in general, the genes associated with fatty acid 
biosynthesis still resulted in an increased cell size; while it is possible that targeting the 
genes associated with fatty acid biosynthesis may not result in an increase in cell size as 
there are critical components missing to form a cell wall, this behavior was not observed. 
This is another indication that the pSRNA system could use some improvements in 
regard to its efficacy; finding a way to make the sRNA suppress growth with less of a 
delay would be a great starting point. This being said, the plasmid-based sRNA system 
does not appear to be leaky, considering the uninduced strains still had a relatively 
unaffected cell size and optical density.  
The gene folA, which was shown to suppress growth when targeted with the afsRNA, is 
also only involved in one reaction – catalyzing the final step of the dihydrofolate 
reduction reaction wherein tetrahydrofolate is formed. Although folA has been shown to 
be a gene essential for viability, the gene folM has been shown to contain the same 
enzymatic activity as folA and may be one reason there was a delay in the time of 
induction to the time growth was suppressed.52 Nonetheless, all variants considered, folA 
was shown to be a relatively successful gene target as the uninduced variant had no 
practical lag and reached a stationary phase with the same OD as the background wild-
type BW25113 strain. murA was an interesting gene target as it was shown not to be 
essential for viability in a knock-out strain grown in LB media, but grown in a modified, 
minimal version of LB media it was shown essential for growth; this suggests that it may 
be a good target for practical applications wherein a seed may be grown in an enriched 
media without fear of unintended growth suppression before transferring to a more 
minimal media where growth suppression has been shown to occur.52 The results of the 
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optical density data show that, like many of the other sRNA-mediated gene targets, there 
is a delay in the time of induction relative to when growth is actually suppressed. The 
growth does appear to be suppressed though it is worth noting that relative to the 
bacteriostatic additives there is quite a delay after induction time for this to occur. The 
delay in the uninduced pSRNA-murA variant may be due to the streptomycin resistance, 
as a similar delay was observed in the bacteriostatic additive experiment where a plasmid 
only containing streptomycin resistance was screened. Nonetheless, there was a notable 
size increase in the pSRNA-murA variant which is interesting as the murA gene is 
essential in the formation of the peptidoglycan layer in cells; this suggests there might not 
be totally efficient repression of the gene in cells, allowing it to still be expressed to some 
degree, resulting in filamentation.52,53 Ultimately murA was a relatively effective gene 
target for growth suppression.  
The genes rplD, rplP, and rpsE also showed relatively good growth suppression, as 
mentioned above, and they all target protein synthesis in the cell. The gene rplD codes 
for a ribosomal subunit protein on the 50S ribosome, the L4 site; the gene rplP is also on 
the 50S ribosome, but the L16 site.53 On the other hand, the gene rpsE is on the 30S 
ribosomal site, and codes for the S5 subunit protein; these three genes all had relatively 
good growth suppression, but with notably high delays. Their morphology was quite 
interesting, as they experienced significant filamentation but no more than the genes 
which targeted fatty acid biosynthesis, which was left unrestricted in this approach, 
though targeting protein synthesis inherent affect fatty acid biosynthesis. The uninduced 
variants for these gene targets did not experience any significant filamentation relative to 
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the background strain indicating good control of plasmid expression for these gene 
targets as they also had a similar final OD.  
In addition to fabB, the genes fabG, folP, and rpsD did not show significant growth 
suppression though they are listed as essential for viability in minimal media; this could 
be due to a multitude of reasons such as the target binding sequence being less than 
optimal, the plasmid being unstable, the build-up of intermediates, or even an increase in 
size skewing the optical density data, which assumes spherical cells.53 The binding 
energy and nucleotide length of each sequence were designed according to experimental 
evidence that showed the most effective blocking of translation for the target gene, so it is 
unlikely changing this would have any effect, but ways to increase plasmid stability and 
activity as well as increase the response of induction could shed much more insight into 
the efficacy of the plasmid based system.41  
In summary, the plate reader experiment showed that some growth-essential genes were 
not effective targets for the pSRNA system, such as fabB; the results also showed an 
increase in the size across the board for all of the induced pSRNA variants, which may 
have further implications in the efficacy of the system. The uninduced pSRNA variants 
showed the same phenotypes as the background strain in regards to optical density and 
morphology, and induction of the background strain did not show any significant 
differences which makes sense because it does not contain the pSRNA system. In the 
case of the fabB gene in particular, associated pathways were considered and a fabH 
construct was generated which did result in growth suppression; the fabBH construct was 
generated as an attempt to make the approach work better. Potential reasons for the lack 
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of growth suppression for relevant, essential gene targets could be plasmid instability 
wherein the plasmid may not have a strong binding affinity or may not work consistently, 
intermediate build-up rendering the cells to continue functioning for a period of time after 
induction, or filamentation which may increase nutrient flux, enabling cells to remain 
viable. Though the scatterplot in Figure 15 suggests there was no significant contribution 
in the optical density as a result of the filamentation, integrating the pSRNA plasmid 
containing each gene target onto the chromosome or also targeting genes responsible for 
filamentation may shed more insight into why these were ineffective at suppressing 
growth relative to the other gene targets. Nonetheless the screening results indicate a 
functional system for the suppression of growth using the afsRNA on a plasmid based 
system in a minimal media, capable of targeting multiple genes as observed in the fabBH 
construct, and also having minimal effect when left uninduced.  
4.2 Bacteriostatic Additive Optical Density Screening Discussion in BW25113 Strains 
As noted, bacteriostatic additives were also explored in this investigation for their ability 
to suppress growth, as well as their effect on morphology, cell viability and metabolic 
activity. The bacteriostatics chloramphenicol (cmp), streptomycin (strep) and tetracycline 
(tet) were added to the background strain BW25113 in a well-plate experiment to first 
assess the effect on growth suppression and morphology. In addition to this, strains 
resistant to each of these bacteriostatic additives were also generated and tested in the 
well-plate experiment to gauge the effect of the plasmid on cell growth and morphology.  
The bacteriostatic chloramphenicol works by binding to the 23S RNA on the 50S subunit 
of the ribosome; the genes rplD and rplP also bind to the 50S subunit of the ribosome 
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though at different sites. In a sense, this bacteriostatic parallels the functionality of 
suppressing these genes. Tetracycline on the other hand binds to the 30S ribosomal site, 
paralleling the functionality of the genes rpsE and rpsD. Tetracycline also binds to the 
30S ribosomal site but targets a different subunit protein.  
In the case of the bacteriostatic additives, it was interesting to note that the streptomycin 
and chloramphenicol did not result in as much filamentation as the tetracycline. While the 
streptomycin appeared to have more filamentation than the chloramphenicol, the 
filamentation did not appear to be as homogenous throughout the sample as it did in the 
tetracycline and it did not appear to be as robust as in the pSRNA variants. Nonetheless, 
all three were effective at stopping growth in the cells and took action much faster than 
the pSRNA system. This sheds light that the delay in growth suppression in the pSRNA 
system is similar to the bacteriostatic system though, in the sense that perhaps both may 
be attributed to the filamentation wherein the cells may be trying to increase nutrient flux 
to counter the lack of essential gene function. Perhaps a higher degree of filamentation 
may be correlated with a longer pseudo-lag phase, though again looking at the scatterplot 
generated in Figure 23 it does not appear the filamentation has any effect on the 
background optical density data in either the strains with and without resistance to 
bacteriostatic additives. The filamentation still suggests that while the cells may be 
dividing, they may still be growing, which still results in nutrient flux being driven away 
from product synthesis. Nonetheless, the bacteriostatic resistant strains did not seem to 
show as much filamentation as the strains with the additives though the streptomycin 
resistant strain had a significant delay in growth which may be a contributing factor to the 
delay in growth observed in the pSRNA variants as they contain streptomycin resistance. 
  89 
 
 
Investigating the bacteriostatic variants for further metabolic activity may shed light to 
their relative efficacy at decoupling growth from production.  
4.3 Viability and Metabolic Activity Screening Discussion in BW25113 Strains 
After the first phase of the study was completed, the optical density and morphology data 
was taken into consideration to select six gene candidates for further investigation in a 
scaled up, shaker flask environment to gauge the cell viability and metabolic activity 
again in BW25113. The six gene candidates, dnaE, fabD, fabH, folA, murA, and rplD, 
represent a diverse array of cellular functionalities associated with the growth process as 
discussed earlier, while also exhibiting efficient suppression of growth in the well plate 
environment. The gene dnaE is responsible in the catalysis of DNA polymerase activity; 
fabD and fabH are involved in cell wall synthesis, with fabD playing a similar role as 
fabB and fabH, as it is involved in the initiation step of fatty acid biosynthesis I as 
discussed above.53 The gene folA is responsible for DNA synthesis, particularly in 
catalyzing the reaction in the final step of the tetrahydrofolate synthesis pathway, and has 
been shown growth essential in knock-out strains; although not explored in this, the gene 
folM has been shown to catalyze the same reaction as folA but folM knockout studies 
have shown this gene is not growth essential.53 Similar to the fab-genes, murA also 
catalyzes cell wall biosynthesis, particularly the first step in the synthesis of the 
peptidoglycan layer in bacteria instead of fatty acid biosynthesis however.53 Finally, rplD 
is a ribosomal subunit protein, L4, and is involved with the synthesis of proteins.53  
Culturing the pSRNA variants containing the aforementioned gene targets in a flask 
environment and monitoring the succeeding viability and metabolic activity gave insight 
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into the redistribution of resources after cell growth was arrested; Figure 25 illustrates the 
dynamic optical density data after induction with aTc. In this figure it may be seen that 
the cells almost immediately suppress growth, with a faster response than observed in the 
well-plate experiment. Not only did the rise in optical density after induction seem 
smaller than it did in the well-plate experiment, the delay was also shorter indicating 
enhanced performance in the flask environment. Adding to this, the glucose was 
consumed in relatively the same amount of time for all of the variants, both induced and 
uninduced, indicating increased metabolic activity; the growth was suppressed for the full 
duration of the experiment – 70 hours. Figure 26 summarizes the specific glucose 
consumption rate relative to the uninduced background strain, a measure of the metabolic 
activity. Figure 26 contains a lot of information; the first thing to note is the unaffected 
specific glucose consumption rate associated with the induced background strain. In the 
first phase of the experiment it was shown that the concentration of anhydrous 
tetracycline used did not have any apparent effect on growth or morphology in the 
background strain, and the findings from this experiment indicate that the anhydrous 
tetracycline did not affect the metabolism of glucose in the background strain either; the 
cells also remained metabolically active as the induced pSRNA variants consumed more 
glucose per cell than the background strain and the uninduced variants; the increased 
metabolic activity seen with the induced pSRNA variants in the minimal media 
environment suggests that they would still be capable of generating phenylalanine after 
suppressing growth. While both the uninduced and induced variants consumed all the 
glucose, because there were less induced cells they had a higher metabolic activity.  
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These results suggest the plasmid based sRNA system is effective at decoupling growth 
from other metabolic processes in the cell, but to confirm the cells remained viable and 
still capable of generating phenylalanine, a viability assay was performed. Shown in 
Figure 27 and Figure 28, viable cells fluoresce green and non-viable cells fluoresce red; 
approximately 100% of the cells appeared to be viable. The few viable cells that were 
spotted amongst the samples were included and may be seen best in Panel 2I and 5I. The 
morphology did not appear to have an effect on the viability of the cells.  
To compare the metabolic activity of the bacteriostatic additives relative to the pSRNA 
system, in the same flask-environment chloramphenicol, streptomycin and tetracycline 
were added at an optical density of ~3.0, as seen in Figure 29. This figure illustrates that 
the bacteriostatic additives were effective at suppressing growth and acted just as fast as 
they did in the well-plate experiment, and just as fast as the pSRNA system did in the 
flask experiment. The growth suppression lasted the duration of the experiment, 80 hours, 
but it is interesting to note the amount of glucose consumed in either of the three cases 
was not as high as the background strain. This suggests that these bacteriostatics have an 
effect on the metabolic activity; considering these bacteriostatics all target 50S or 30S 
subunit of the ribosome, their metabolic activity may best be reflected by the pSRNA-
rplD variant which targets the L4 site of the 50S ribosome. In this variant, the specific 
glucose consumption rate as seen in Figure 26 was the lowest of all the induced pSRNA 
strains, though still higher than the background strain. Even taking this into 
consideration, the strains which received bacteriostatic additives still did not reach a 
specific glucose consumption rate that was as high. While this shows the bacteriostatics 
may be effective at suppressing growth, it shows there may be complications in 
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warranting the continuation of a bioproduct like phenylalanine which is closely tied to 
growth.  
To further investigate the influence of the pSRNA system on the metabolic activity of the 
cell, a fed-batch experiment was conducted wherein the pSRNA-murA variant was once 
more grown in a shaker flask environment, and a charge of nutrients, containing more 
glucose in particular, was added during the exponential phase. The nutrient charge was 
added during the exponential phase because there is an exogenous and endogenous 
accumulation of nucleobases when E. coli cells reach stationary phase that makes it 
unlikely for them to continue to consume nutrients and generate a substantial amount of 
product afterwards, so by targeting the exponential phase and then inducing the variants 
they may continue to consume nutrients while growth is stopped.54  
The dynamic optical density results of this experiment, seen in Figure 31, suggest that the 
cells are able to continue consuming the excess glucose in the fed batch environment. As 
shown before, this data also suggests the aTc has no effect on the metabolic activity of 
the background strain which does not contain the pSRNA system, and it also suggests 
that the pSRNA system has no effect on the metabolic activity of the cell when left 
uninduced. The resulting specific glucose consumption rates from this experiment are 
then summarized in Figure 32; the results suggest that the pSRNA-murA variant has a 
significantly higher glucose consumption rate, around 20% greater than the other strains. 
In the well plate experiment, the uninduced pSRNA-murA variant had a specific glucose 
consumption rate 10% greater than the background strain and the induced, 30%. These 
results are similar to the fed-batch experiment and support the observation that the 
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metabolic activity was not suppressed during the suppression of growth. A mor 
significant observation to note form this experiment, however, is the fact that the induced 
pSRNA-murA variant continued to consume all the glucose from the fed-batch 
experiment.  
4.4 Phenylalanine Production in BW25113 pINT-GA and pSRNA Variants Discussion 
In this final phase of the investigation, the efficacy of the pSRNA system towards 
decoupling growth from the production of phenylalanine, a product known to be tied 
closely to growth, is assessed.55 First the 6 gene targets which were further analyzed after 
the plate reader run, dnaE, fabD, fabH, folA, murA, and rplD were transformed into a 
BW25113 pINT-GA variant. As discussed in the Materials and Methods section, the 
pINT-GA variant produces phenylalanine because it has feedback resistant copies of the 
genes aroG and pheA overexpressed.  
In the plate reader experiment, well-plates were induced at an optical density of ~0.4 as 
before and the resulting dynamic optical density was measured. The results of the plate 
reader experiment were quite interesting and suggest there may be some plasmid 
interference occurring, as the combination of the two plasmids seems to result in worse 
efficiency than either single plasmid individually. Starting with the pINT-GA variant 
which lacks the pSRNA system, it appears as if the addition of aTc still had some effect 
on growth, resulting in a slightly depressed growth cycle after induction. While this effect 
was interesting on the optical density it appeared there was no significant effect in 
regards to cell morphology, suggesting this may not be a significant change in cell 
activity.  
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The pSRNA-dnaE variant appeared to have the worst growth suppression out of all those 
tested in the pINT-GA strain; in this strain it appears that induction resulted in a 
significant degree of activity related to growth suppression but it appears the cell was 
able to overcome these limitations and ultimately replicate, soon reaching a final density 
similar to the control strains. It is also worth noting that the induced dnaE variant 
contained highly elongated morphology that was consistent throughout, and this may be a 
contributing factor as to why there might be an increase in optical density, though the 
data from the murA variant, which also had surprisingly long morphology, suggests 
otherwise. Nonetheless, filamentation might suggest the cells are still directing this 
nutrient flux towards growth in the sense of increasing cell mass without cell division 
taking place. This is definitely an area of research which could shed more light regarding 
the underlying mechanisms of the system. The other gene targets all show relatively 
similar efficiency with regards to growth suppression with the exception of murA which 
appears to suppress growth the best. In the murA variant, the optical density appears to 
keep increasing steadily as it did with the other targets but the rate at which it increases is 
slower than all others suggesting it would not be able to reach the same cell density as the 
control strains, as nutrients may eventually limit this process and the cell may reach a 
point where it no longer may replicate. The morphology of the murA was interesting too; 
it appeared to have the second degree of filamentation, just behind the dnaE variant, but 
the optical density did not appear to increase as significantly suggesting filamentation 
may not have such a significant effect on optical density relative to the sheer number of 
cells, though it is likely a contributing factor to some degree.  
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Ultimately there were mixed morphology results that did not seem to have much of a 
correlation to the final optical density results though it is likely they did contribute to any 
background increases in optical density as summarized in the scatterplot generated in 
Figure 38. The significance of this interaction should be further investigated to more 
accurately gauge the cell mass in the culture, but taking this into consideration the results 
suggest it is possible that there is some interference between these two plasmids, with 
strains like dnaE showing worse growth suppression than it did in the BW25113 
background strain (seen in Figure 8). Testing the pSRNA system in a strain which has the 
genes to make phenylalanine on the chromosome, such as NST74, might shed more light 
into the efficacy of the growth suppression.  
For its efficient growth suppression and consistency from the first phase of the 
investigation, the BW25113 pINT-GA pSRNA-murA variant was chosen to run in a 
shaker-flask experiment wherein a metabolite analysis tracked the dynamic consumption 
of glucose as well as the production of acetate and phenylalanine. The results of the 
optical density from the shaker flak experiment may be seen in Figure 39 and suggest 
interesting phenomena.  
In the shaker flask experiment the first thing to note is that the uninduced pSRNA variant 
has a larger optical density than the background pINT-GA strain; in the plate-reader 
experiment the two strains essentially grew at the same rate. This suggests there may be 
an inherent increase in nutrient flux towards growth, where growth could be summarized 
by cell division and filamentation. In the case of the uninduced pSRNA variant where 
cell division is left uninhibited, the cells filament and also divide. The second thing to 
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note is that, while the aTc did not have any effect on the metabolic activity or cell 
viability of the background pINT-GA strain in the shaker-flask experiment, though it did 
appear to have an insignificant but present effect in the well-plate experiment, the aTc did 
seem to have an effect on the pSRNA-murA variant suggesting growth may have been 
decoupled from biomass synthesis. More interesting to note in the case of the pSRNA-
murA variant is not necessarily that the aTc had an effect on the growth, but that the two 
induction times ultimately resulted in the same final optical density. This suggests that 
the time of induction might not have as significant of an effect on the final optical density 
as one would have expected, but the implications of this on the phenylalanine production 
do not appear to have the same lack of sensitivity.  
Looking next at the pINT-GA and the pSRNA-murA variant in regards to glucose 
consumption in the uninduced and induced types, all of the strains appear to have 
consumed glucose in relatively the same amount of time suggesting that the pSRNA 
system does not appear to inhibit any metabolic activity even in the double-plasmid 
pINT-GA pSRNA system. This results in an inherently higher specific glucose 
consumption rate relative to the uninduced strains. While there is a lot of similarity 
amongst the strains, the phenylalanine production is a bit, most notably there is 
significantly less phenylalanine being produced in the pINT-GA pSRNA-murA variant 
than in the pINT-GA background variant. As shown in Figure 35, while there does appear 
to be a similarity in the sense that majority of the phenylalanine was made during the 
exponential growth phase with a bit of residual phenylalanine synthesized during 
stationary phase, further analysis reveals more interesting observations. In the pINT-GA 
background strain it seems as if not as much phenylalanine is generated during the 
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exponential phase as in the pSRNA-murA variants, capping out close to ~0.8 grams per 
liter versus ~1.0 grams per liter, but during stationary phase these cells seem much more 
active, effectively generating ~1.3 grams per liter versus the range of ~1.0 to ~0.8 grams 
per liter seen in the pSRNA-murA variant. In the pSRNA-murA variants, particularly the 
uninduced strain, there appears to be a depression in the phenylalanine concentration 
immediately after exponential phase where some of the phenylalanine appears to be 
reuptaken; while this appears to be regenerated near the end of the duration of the study it 
never reaches a level as high as the pSRNA-murA variant which was induced at the 
second time point, late in the exponential phase. The second time point of induction does 
not appear to experience any depression in phenylalanine concentration and continues to 
make a bit of phenylalanine for the duration of the study. Unfortunately the first time 
point of induction did not appear to be as good as either of the other two pSRNA-murA 
strains in regards to phenylalanine generation, not making any significant quantities of 
phenylalanine after the exponential phase. 
These results indicate that, while the pSRNA system was relatively effective at 
decoupling growth from the production of phenylalanine, it was not as effective as one 
might hope. Whereas in the optical density data the system seemed insensitive to 
induction point versus relative final cell density, as the two induction time points leveled 
off at the same final cell density, the results suggest the phenylalanine production is a bit 
more sensitive. By manipulating the time of induction to be just right, it was shown that 
the induced pSRNA variant beat the uninduced pSRNA variant, though it was not enough 
to out-perform the strain which lacked the pSRNA plasmid. Once more tightening the 
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degree to which filamentation occurs and making the pSRNA act faster after induction 
may be contributing factors to the room for improvement.  
Gauging the acetate production shed interesting observations as well; it was found that 
the presence of the pSRNA plasmid resulted in much less acetate production across the 
board relative to the pINT-GA strain without the pSRNA plasmid. As was the case with 
the phenylalanine production, much of the production of acetate was made during the 
exponential phase, but in both cases any acetate was reuptaken during the stationary 
phase. Coupling this with the results from the optical density and glucose consumption 
data suggests interesting possibilities. It may be possible that the acetate generated during 
the exponential phase in the pINT-GA strain, when reuptaken during the stationary phase, 
was responsible for the increase in phenylalanine which was observed; this increase 
during the stationary phase was not seen in the pSRNA variants, and the pSRNA variants 
also did not generate nearly as much acetate. As acetate is generated when glucose is 
being consumed too fast, this also supports the suggestion that the two-plasmid system 
may result in an interference which puts a burden on the cell which requires it to 
inherently consume more glucose to remain viable, leaving less for the production of both 
acetate and ultimately phenylalanine, though this is an interesting proposition because 
acetate is associated with suppressed cell growth.55 While acetate is generally used as an 
indication that the cell is under stress, consuming glucose too fast, in this case it might be 
desirable to see a build-up of acetate in the pINT-GA pSRNA variants as it might 
indicate there is free glucose which may be converted to a useful product; the degree of 
acetate production and if there is any correlation to the final titer of phenylalanine should 
be explored in more depth.  
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Nonetheless, the final metrics to gauge the performance of the pINT-GA strain with the 
pSRNA system may be summarized in Figure 42; seen in this figure, four metrics are 
generated – the final phenylalanine concentration, the grams of phenylalanine produced 
per grams of glucose consumed, the grams of phenylalanine produced per mass of cells, 
and the grams of cell mass produced per gram of glucose consumed. Ideally, decoupling 
growth from production would result in increases in grams of phenylalanine per grams of 
glucose and per grams of cell mass as well as a decrease in the amount of cell mass per 
grams of glucose. While there is a trend that suggests this may be occurring to some 
degree, it is only seen with respect to the second time point of induction and the increases 
do not succeed those of the pINT-GA strain lacking the pSRNA system entirely.  
In all metrics, the pINT-GA strain lacking the pSRNA system performs best – it makes 
the most phenylalanine, per gram of glucose and cell mass, and makes the lowest amount 
of cell mass per gram of glucose as well. It is worth noting that with respect to the grams 
of cell mass per grams of glucose, the two induced pSRNA variants are equivalent, and 
looking at the uninduced pSRNA strain it is apparent the pSRNA system is effective at 
decoupling growth, though it is also apparent it inherently directs more resources towards 
growth, which is likely a combination of filamentation and cell division. Nonetheless, 
there is not much of an observable difference in the grams of cell mass per grams of 
glucose with respect to the two induction times, a reflection of the optical density data 
showing they leveled out at the same cell density, which shows the sensitivity to 
induction may be a target for further investigation. With respect to the total amount of 
phenylalanine produced, it does not appear that the aTc has an effect on the strain which 
lacks the pSRNA system as one might expect. Though the strain lacking the pSRNA 
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system did generate more phenylalanine, again it appears that the pSRNA system was 
relatively efficient at directing nutrient flux away from growth and towards production of 
phenylalanine. Compared to the control, making ~10% more phenylalanine (1 gram per 
liter versus 0.9 gram per liter), even considering it had a suppressed OD600 (6.5 versus 
8.7). Ultimately this suggests there is more work that needs to be done in regards to 
upping the total phenylalanine generated. The grams of phenylalanine produced per 
grams of glucose, and grams of phenylalanine per grams of cell mass are again highest in 
the second induction time amongst the pSRNA-murA variants, suggesting that the system 
was efficient to some degree at decoupling growth from production, but it was not 
enough to offset the apparent interaction between the two plasmids which resulted in 
inherently less phenylalanine being generated. While the first time point of induction 
produced more phenylalanine per cell mass, when normalized to the amount of glucose it 
did not outperform the uninduced strain. This suggests that the timing of induction has a 
large influence on decoupling the growth from production – likely a reflection of the 
observation that the first time point of induction did not result in a lower cell density than 
the second time point of induction.  
Ultimately while the system was shown to be relatively effective at accomplishing the 
tricky feat of decoupling biomass synthesis from the production of phenylalanine, this 
investigation opens a lot of potential for improvements, such as focusing on increasing 
the performance and efficacy of the system, selecting other interesting biological systems 
to metabolically engineer using the pSRNA approach, and investigating other 
bioproducts which may benefit from this approach.  
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5. CONCLUSIONS 
5.1 Summary of Observations  
In conclusion, it was ultimately found that the plasmid-based afsRNA system was 
effective at inhibiting growth by blocking the translation of growth-essential genes, with 
different degrees of growth suppression and interesting morphology changes associated 
with each gene target; the system was also found to be relatively effective at redirecting 
nutrient flux towards the production of phenylalanine when targeting the gene murA. 
Cells remained more metabolically active than a comparison done with bacteriostatic 
additives, with a higher specific glucose consumption rate, but had a higher degree of 
fillamentation growth took longer to suppress in the well-plate experiment. While the 
resulting efficiencies may be an indication regarding the relative essentiality of each gene 
target, it may also be a reflection of the efficacy of the afsRNA approach. Nonetheless, 
the system was shown capable of targeting more than one gene at once, as it was 
demonstrated that two afsRNA scaffolds could be combined on the same plasmid without 
affecting efficiency of either (the fabBH construct performed as well as the fabB and 
fabH did, individually), and the system was shown to remain metabolically active in a 
fed-batch environment. It was also shown the pSRNA-murA plasmid was able to be co-
transformed with the pINT-GA plasmid, though in this case it is worth noting a bit of 
interference was observed which resulted in a diminished background performance. 
Although filamentation associated with the pSRNA variants was consistently observed 
across the board with some gene targets resulting in higher degrees of morphology 
changes than others, the double-plasmid pINT-GA pSRNA variants had the highest 
degree of fillamentation, suggesting this is a suitable area for further investigation.  
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Furthermore, in the strain where the plasmid pINT-GA was co-transformed with the 
pSRNA plasmid, the results showed the system was working but there was much room 
for improvement. While significant increases in both final titer and specific yields of 
phenylalanine were observed in the variant that was induced at the second time point, 
relative to the uninduced double-plasmid variant and the one induced at the first time 
point, these increases in efficiency did not outweigh the single-plasmid pINT-GA strain 
where the pSRNA plasmid was not present. There appeared to be a general background 
increase in nutrient flux away from phenylalanine production and towards growth in the 
strain which the pSRNA was not induced, relative to the strain without the pSRNA.  
Ultimately the system constructed was shown to work moderately well, addressing the 
tricky problem of decoupling biomass synthesis from growth; further improvements on 
this system may make it a formidable tool to use on an industrial scale as it is versatile 
and not limited to targeting one particular cell mechanism or one particular product 
pathway but rather may be used in a plethora of applications related to metabolic 
engineering considering there are still many improvements to be made.   
5.2 Suggestions and Future Aims  
Future research related to this project may extend in many directions with a lot of 
possible depth; in general, the most interesting candidates for future research may be the 
filamentation (particularly of the induced cells), the time it takes after induction for 
growth to stop, the effect of induction time, the relationship between acetate production 
and performance of the system, exploration of gene targets related to other aspects of 
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cellular processes that may be coupled with current candidates from this paper, and 
applications in different strains to name a few.  
The relationship filamentation has with many factors in this investigation is quite 
interesting; first, accounting for the filamentation to achieve more accurate cell density 
measurements may shed more light into the efficacy of the system, though the results 
from the pINT-GA plate reader experiment indicate this probably did not play as 
significant of a role as expected. This may require a calibration curve relating optical 
density to dry cell mass, for various degrees of fillamentation. Second, targeting genes 
associated with filamentation and coupling this with the growth-essential genes may 
increase the efficacy of the system and would be especially interesting to observe in the 
pINT-GA pSRNA double-plasmid scenario. It would also be interesting to explore other 
strategies at suppressing filamentation of the cells, in addition to suppressing cell division 
– such strategies may involve a synthetic oscillator switch, which may cycle the 
expression of the pSRNA plasmid so as to block growth essential genes long enough to 
prevent increases in cell density, but short enough to prevent the cell from filamenting.56 
Seeing if there is any relationship between the delay between induction time and growth 
suppression, and the final degree of filamentation might also be interesting, as well as 
acetate production and final degree of filamentation would be interesting a well – 
ultimately, characterizing the effect of filamentation on the overall performance of the 
system would shed a lot of light into the underlying mechanism of the plasmid-based 
afsRNA approach. Somewhat related to the degree of filamentation, it would also be 
interesting to further explore the effect of various induction times during the exponential 
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phase as the system did not have a sensitive response to this in regards to growth 
suppression but did appear to have a sensitive response to this in regards to phenylalanine 
production.  
Branching off of this, integrating the sRNA plasmid on chromosome may show cleaner 
results across the board as well. Furthermore, because the strain used to make 
phenylalanine was also plasmid-based, testing the pSRNA system in a strain like NST74 
in which the genes to make phenylalanine are on the chromosome would be an interesting 
comparison, as would the efficacy of bacteriostatics at making phenylalanine as it was 
found they are not as efficient at keeping metabolic activity unscathed. Other products 
would also be interesting to investigate in conjunction with the sRNA, even in other 
scenarios for example in which it may not be used to necessarily target growth essential 
genes but perhaps a step branching off to a competing pathway which could result in the 
build-up of a rate limiting intermediate product, in turn increasing the titer and yield of a 
desired pathway. Ultimately, the plasmid based sRNA approach was found to show a lot 
of potential, but like anything interesting the possibilities for further investigation are 
nearly endless; addressing some of the questions raised in this section may make this a 
formidable technique to be used on an industrial scale, as it may retrofit completely with 
existing technologies.  
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APPENDIX A  
sRNA NUCLEOTIDE SEQUENCE USED IN CONSTRUCTION OF PLASMID 
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TCCCTATCAGTGATAGAGATTGACATCCCTATCAGTGATAGAGATACTGAGCACCTA
GGATGCTTAACCAGCTCGATAACCTGTTTCTGTTGGGCCATTGCATTGCCAC
TGATTTTCCAACATATAAAAAGACAAGCCCGAACAGTCGTCCGGGCTTTTTTT
CTCGAGCTCGAGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACT
GGGCCTTTCGTTTTATCTGTTTTTGTCGGTGAACGCTCTCTACTAGAGTCACAC
TGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATA 
Figure 45: The Nucleotide Sequence Used to Construct the Modular Synthetic sRNA 
showing the Anhydrous Tetracycline Promoter Sequence (Italics), the Target Binding 
Sequence (Bold), the MicC sRNA Scaffold Sequence (Underlined), and the T1/TE 
Terminator Sequence (Normal). 
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APPENDIX B  
NUCLEOTIDE TARGET BINDING SEQUENCES OF THE SEED REGIONS USED 
IN afsRNA
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Table 4: Coding and Target Binding Sequences as well as Binding Energies for the 
Different Candidate Gene Targets 
nt   
sRNA 
gene 
targets 
Coding sequence (5' 
 3')   
Target-binding 
sequence (5' -> 3')   
Binding 
energy 
(kcal/mol) 
23   dnaE   ATG TCT GAA CCA CGT TTC GTA CA 
TGT ACG AAA CGT 
GGT TCA GAC AT -38.7 
23   fabB   ATG AAA CGT GCA GTG ATT ACT GG 
CCA GTA ATC ACT 
GCA CGT TTC AT -38 
24   fabD   ATG ACG CAA TTT GCA TTT GTG TTC 
GAA CAC AAA TGC 
AAA TTG CGT CAT  -37.4 
24   fabG   ATG AAT TTT GAA GGA AAA ATC GCA 
TGC GAT TTT TCC 
TTC AAA ATT CAT  -34.1 
26   fabH   
ATG TAT ACG AAG 
ATT ATT GGT ACT 
GG 
CC AGT ACC AAT 
AAT CTT CGT ATA 
CAT  
-39.2 
23   fabI   ATG GGT TTT CTT TCC GGT AAG CG 
CGC TTA CCG GAA 
AGA AAA CCC AT -39 
20   folA   
ATG CGG CGA 
GTC CAG GGA 
GA 
  
TC TCC CTG 
GAC TCG CCG 
CAT  
  -41.9 
23   folD   ATG GCA GCA AAG ATT ATT GAC GG 
CCG TCA ATA ATC 
TTT GCT GCC AT -38 
23   folP   GTG CTC CGG GGT TTT TTC TTA TC 
GAT AAG AAA AAA 
CCC CGG AGC AC -39.4 
26  lacZ  
ATG ACC ATG ATT 
ACG GAT TCA CTG 
GC 
GC CAG TGA ATC 
CGT AAT CAT GGT 
CAT 
-34.8 
24   murA   ATG GAT AAA TTT CGT GTT CAG GGG 
CCC CTG AAC ACG 
AAA TTT ATC CAT  -38.9 
24   rplD   ATG GAA TTA GTA TTG AAA GAC GCG 
CGC GTC TTT CAA 
TAC TAA TTC CAT  -36.5 
24   rplP   ATG TTA CAA CCA AAG CGT ACA AAA  
TTT TGT ACG CTT 
TGG TTG TAA CAT  -35.8 
24   rpsD   ATG GCA AGA TAT TTG GGT CCT AAG 
CTT AGG ACC CAA 
ATA TCT TGC CAT  -39.5 
23   rpsE   ATG GCT CAC ATC GAA AAA CAA GC 
GCT TGT TTT TCG 
ATG TGA GCC AT -38.4 
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APPENDIX C 
LIST OF STRAINS AND VARIANTS USED IN THIS STUDY 
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Table 5: List of All Strain Names and a Description; 1DH5-alpha was sourced from 
ThermoFisher, 2BW25113 was sourced from CGSC, 3NST74 and ZM4 were sourced 
from ATCC, and all else from This Study 
Strains Description 
E. coli DH5-alpha1 
dlacZ Delta M15 Delta(lacZYA-argF) U169 recA1 endA1 hsdR17(rK-mK+) 
supE44 thi-1 gyrA96 relA1 
E. coli BW251132 
F-, DE(araD-araB)567, lacZ4787(del)::rrnB-3, LAM-, rph-1, DE(rhaD-
rhaB)568, hsdR514 
E. coli NST743 aroH367, tyrR366, tna-2, lacY5, aroF394(fbr), malT384, pheA101(fbr), pheO352, aroG397(fbr) 
Z. mobilis ZM43 See References44 
E. coli MG1655 K-12 F– λ– ilvG– rfb-50 rph-1 
MG1655-lacZ E. coli MG1655 pSRNA-lacZ 
BW-cmp E. coli BW25113 pACYC-DUET 
BW-strep E. coli BW25113 pCDF-DUET 
BW-tet E. coli BW25113 pRK415 
BW-dnaE E. coli BW25113 pSRNA-dnaE 
BW-fabB E. coli BW25113 pSRNA-fabB 
BW-fabBH E. coli BW25113 pSRNA-fabBH 
BW-fabD E. coli BW25113 pSRNA-fabD 
BW-fabG E. coli BW25113 pSRNA-fabG 
BW-fabH E. coli BW25113 pSRNA-fabH 
BW-fabI E. coli BW25113 pSRNA-fabI 
BW-folA E. coli BW25113 pSRNA-folA 
BW-folD E. coli BW25113 pSRNA-folD 
BW-folP E. coli BW25113 pSRNA-folP 
BW-murA E. coli BW25113 pSRNA-murA 
BW-rplD E. coli BW25113 pSRNA-rplD 
BW-rplP E. coli BW25113 pSRNA-rplP 
BW-rpsD E. coli BW25113 pSRNA-rpsD 
BW-rpsE E. coli BW25113 pSRNA-rpsE 
pINT-GA E. coli BW25113 pINT-GA 
pINT-GA dnaE E. coli BW25113 pINT-GA pSRNA-dnaE 
pINT-GA fabD E. coli BW25113 pINT-GA pSRNA-fabD 
pINT-GA fabH E. coli BW25113 pINT-GA pSRNA-fabH 
pINT-GA folA E. coli BW25113 pINT-GA pSRNA-folA 
pINT-GA murA E. coli BW25113 pINT-GA pSRNA-murA 
pINT-GA rplD  E. coli BW25113 pINT-GA pSRNA-rplD 
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APPENDIX D 
ASSORTED MEDIA RECIPES 
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Miller’s LB contains 10 grams of tryptone, 5 grams of yeast extract, and 10 grams of 
sodium chloride per liter of solution; the Miller’s LB powder used in this study is pre-
formulated (Growcells).  
To generate a 50 milliliter shake flask of M9 minimal media, 100 microliters of 1M 
MgSO4 (Caroline Biological Supply Co.), 5 microliters of CaCl2 (Sigma Aldrich), 10 
milliliters of 5X M9 salts, 5 milliliters of 20% (w/v) glucose (Sigma Aldrich), and 35 
milliliters of deionized water. The 5X M9 salts are comprised of 64 grams of Na2HPO4 
(Santa Cruz), 15 grams of KH2PO4 (G Biosciences), 2.5 grams of NaCl (Sigma Aldrich), 
and 5 grams of NH4Cl (MP Biochemicals).  
M9M was comprised of 11.33 grams of Na2HPO4 heptahydrate, 3 grams of KH2PO4, 0.5 
grams of NaCl, 2 grams of NH2Cl for half a liter of a stock solution. To generate a 50 
milliliter flask, 25 milliliters of this solution were mixed with 20 milliliters of water, 5 
milliliters of 20% (w/v) glucose, 50 microliters of MgSO4 and 5 microliters of CaCl2.  
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APPENDIX E 
POST-PROCESSING METHODOLOGY FOR AUTOMATIC CELL SIZE 
DISTRIBUTION 
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As a demonstration of the post processing method used to determine the relativistic cell 
sizes, consider starting with the images below, which display the morphology of 
BW25113 pSRNA-folA when uninduced and induced,  
 
Figure 46: Microscopy Images of BW-folA Without the Addition of aTc (Left) and With 
the Addition of aTc (Right) 
Opening these images in the ImageJ program, a threshold may be applied to effectively 
convert them to black and white. From this point it is a bit clearer that the induced cells 
have a larger morphology, but hard to quantify, especially with background noise,  
 
Figure 47: Microscopy Images of BW-folA Without the Addition of aTc (Left) and With 
the Addition of aTc (Right) after a Threshold is Applied 
The images may then be duplicated, where a Gaussian blur filter may be applied to 
smooth out background noise and artifacts in the image. The original image with the 
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threshold applied may once more be subtracted from the Gaussian blurred image to 
reveal an image with less background noise. Applying a threshold on this image once 
more reduces the amount of noise present in the image.  
 
Figure 48: Microscopy Images of BW-folA Without the Addition of aTc (Left) and With 
the Addition of aTc (Right) after applying a Gaussian Blur, Subtracting this from the 
Original, and Once more applying a Threshold 
Finally, using the particle analysis tool built into ImageJ, clean results may be obtained 
for average particle size distribution,  
 
Figure 49: Results from the Particle Size Distribution Analysis Using ImageJ 
Results from this analysis in particular showed the induced cells were 2.18 times larger 
than the uninduced cells.  
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APPENDIX F 
SELECTED PLATE READER OD600 DATA FOR BW25113 AND STRAIN 
VARIANTS IN LB 
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Figure 50: Data Showing the Relationship between Optical Density and Time for Various 
Strains in LB, Induced with 0.5 Microliters of Anhydrous Tetracycline (aTc) per 
Milliliter of Culture, Relative to the Background Strain BW25113 without aTc and the 
Respective Uninduced Strain Variant. (Top Left, BW25113, no sRNA plasmid, with aTc; 
Top Right, BW-dnaE; Bottom Left, BW-fabB; Bottom Right, BW-fabBH). 
 
Figure 51: Data Showing the Relationship between Optical Density and Time for Various 
Strains in LB, Induced with 0.5 Microliters of Anhydrous Tetracycline (aTc) per 
Milliliter of Culture, Relative to the Background Strain BW25113 without aTc and the 
Respective Uninduced Strain Variant. (Top Left, BW-fabD; Top Right, BW-fabG; 
Bottom Left, BW-fabH; Bottom Right, BW-fabI). 
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Figure 52: Data Showing the Relationship between Optical Density and Time for Various 
Strains in LB, Induced with 0.5 Microliters of Anhydrous Tetracycline (aTc) per 
Milliliter of Culture, Relative to the Background Strain BW25113 without aTc and the 
Respective Uninduced Strain Variant. (Top Left, BW-folA; Top Right, BW-folD; Bottom 
Left, BW-folP; Bottom Right, BW-murA). 
 
Figure 53: Data Showing the Relationship between Optical Density and Time for Various 
Strains in LB, Induced with 0.5 Microliters of Anhydrous Tetracycline (aTc) per 
Milliliter of Culture, Relative to the Background Strain BW25113 without aTc and the 
Respective Uninduced Strain Variant. (Top Left, BW-rplD; Top Right, BW-rplP; Bottom 
Left, BW-rpsD; Bottom Right, BW-rpsE. 
